PY5 |
Alameda Health System |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0344 |
0 |
0.0848 |
None |
36 |
0 |
786 |
0 |
4.6% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
52 |
0 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
52 |
0 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
20 |
0 |
52 |
0 |
38.5% |
0 |
N/A |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.1731 |
0 |
0.1522 |
None |
82 |
0 |
401 |
0 |
20.5% |
0 |
1 |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.2923 |
0 |
0.2609 |
None |
135 |
0 |
401 |
0 |
33.7% |
0 |
1 |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.6 |
0 |
0.6069 |
None |
296 |
0 |
401 |
0 |
73.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.1503 |
0 |
0.1583 |
None |
88 |
0 |
318 |
0 |
27.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.1933 |
0 |
0.2066 |
None |
102 |
0 |
318 |
0 |
32.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
None |
2 |
0.0269 |
None |
11 |
0 |
772 |
0 |
1.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.555 |
0 |
0.5663 |
None |
2637 |
0 |
4503 |
0 |
58.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.9138 |
0 |
0.9144 |
None |
382 |
0 |
416 |
0 |
91.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.9344 |
0 |
0.9199 |
None |
982 |
0 |
1058 |
0 |
92.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.9765 |
0 |
0.8775 |
None |
503 |
0 |
510 |
0 |
98.6% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7692 |
0 |
0.7761 |
None |
4159 |
0 |
5488 |
0 |
75.8% |
0 |
0 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.4344 |
0 |
0.425 |
None |
462 |
0 |
1163 |
0 |
39.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3763 |
0 |
0.3727 |
None |
500 |
0 |
1222 |
0 |
40.9% |
0 |
0 |
0 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3839 |
0 |
0.3796 |
None |
1526 |
0 |
4079 |
0 |
37.4% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
233 |
0 |
928 |
0 |
25.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
457 |
0 |
1143 |
0 |
40.0% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
36 |
0 |
86 |
0 |
41.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
180 |
0 |
439 |
0 |
41.0% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
72 |
0 |
43.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
583 |
0 |
1397 |
0 |
41.7% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1526 |
0 |
4079 |
0 |
37.4% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
500 |
0 |
1222 |
0 |
40.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
926 |
0 |
2711 |
0 |
34.2% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
100 |
0 |
146 |
0 |
68.5% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1526 |
0 |
4079 |
0 |
37.4% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5293 |
0 |
0.5394 |
None |
2218 |
0 |
4079 |
0 |
54.4% |
0 |
1 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.6017 |
0 |
0.4676 |
None |
2111 |
0 |
3553 |
0 |
59.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8313 |
0 |
0.8319 |
None |
427 |
0 |
505 |
0 |
84.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9786 |
0 |
0.78 |
None |
1931 |
0 |
1956 |
0 |
98.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Childhood Immunization Status (CIS 10) - -Black/African American |
Reported |
0.2967 |
0 |
0.3207 |
None |
35 |
0 |
91 |
0 |
38.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
None |
None |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Exclusive Breast Milk Feeding (PC-05) - -Asian |
Reported |
0.6304 |
0 |
0.6436 |
None |
39 |
0 |
59 |
0 |
66.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1381 |
0 |
0.22 |
None |
69 |
0 |
376 |
0 |
18.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.694 |
0 |
0.7008 |
None |
718 |
0 |
992 |
0 |
72.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7496 |
0 |
0.7583 |
None |
489 |
0 |
613 |
0 |
79.8% |
0 |
1 |
1 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
59 |
0 |
64 |
0 |
92.2% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
107 |
0 |
137 |
0 |
78.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
60 |
0 |
78.3% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
259 |
0 |
322 |
0 |
80.4% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
489 |
0 |
613 |
0 |
79.8% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
222 |
0 |
268 |
0 |
82.8% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
255 |
0 |
314 |
0 |
81.2% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
31 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
489 |
0 |
613 |
0 |
79.8% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.7979 |
0 |
0.8103 |
None |
479 |
0 |
613 |
0 |
78.1% |
0 |
0 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
48 |
0 |
64 |
0 |
75.0% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
113 |
0 |
137 |
0 |
82.5% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
60 |
0 |
76.7% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
252 |
0 |
322 |
0 |
78.3% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
479 |
0 |
613 |
0 |
78.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
220 |
0 |
268 |
0 |
82.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
251 |
0 |
314 |
0 |
79.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
31 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
479 |
0 |
613 |
0 |
78.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.454 |
0 |
0.4544 |
None |
259 |
0 |
603 |
0 |
43.0% |
0 |
0 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9805 |
0 |
0.9434 |
None |
875 |
0 |
898 |
0 |
97.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.9433 |
0 |
0.9199 |
None |
563 |
0 |
601 |
0 |
93.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.4642 |
0 |
0.4816 |
None |
2680 |
0 |
5547 |
0 |
48.3% |
0 |
1 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.6044 |
0 |
0.6279 |
None |
409 |
0 |
575 |
0 |
71.1% |
0 |
1 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.6795 |
0 |
0.6834 |
None |
16086 |
0 |
20506 |
0 |
78.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.7017 |
0 |
0.7214 |
None |
15950 |
0 |
21335 |
0 |
74.8% |
0 |
1 |
1 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.7709 |
0 |
0.7731 |
None |
5637 |
0 |
6070 |
0 |
92.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.7744 |
0 |
0.7794 |
None |
5614 |
0 |
6070 |
0 |
92.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.9125 |
0 |
0.8718 |
None |
5492 |
0 |
6070 |
0 |
90.5% |
0 |
1 |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.5938 |
0 |
0.6028 |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6153 |
0 |
0.6643 |
None |
393 |
0 |
557 |
0 |
70.6% |
0 |
1 |
0 |
YesS |
PY5 |
Alameda Health System |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4437 |
0 |
0.4613 |
None |
5257 |
0 |
12578 |
0 |
41.8% |
0 |
0 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
538 |
0 |
1314 |
0 |
40.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
533 |
0 |
1483 |
0 |
35.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
134 |
0 |
35.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
178 |
0 |
513 |
0 |
34.7% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
71 |
0 |
147 |
0 |
48.3% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
3881 |
0 |
8963 |
0 |
43.3% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
5257 |
0 |
12578 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3451 |
0 |
7198 |
0 |
47.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1622 |
0 |
3919 |
0 |
41.4% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
184 |
0 |
1461 |
0 |
12.6% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
5257 |
0 |
12578 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.4478 |
0 |
0.4567 |
None |
316 |
0 |
558 |
0 |
56.6% |
0 |
1 |
1 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
57 |
0 |
64.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
87 |
0 |
39.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
225 |
0 |
375 |
0 |
60.0% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
316 |
0 |
558 |
0 |
56.6% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
200 |
0 |
304 |
0 |
65.8% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
114 |
0 |
226 |
0 |
50.4% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
316 |
0 |
558 |
0 |
56.6% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6695 |
0 |
0.6615 |
None |
1145 |
0 |
1648 |
0 |
69.5% |
0 |
1 |
1 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5915 |
0 |
0.5928 |
None |
7411 |
0 |
12271 |
0 |
60.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.4363 |
0 |
0.3665 |
None |
799 |
0 |
1207 |
0 |
66.2% |
0 |
1 |
1 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.6846 |
0 |
0.6263 |
None |
15882 |
0 |
21709 |
0 |
73.2% |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3608 |
0 |
0.3753 |
None |
281 |
0 |
584 |
0 |
48.1% |
0 |
1 |
1 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
53 |
0 |
43.4% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
60 |
0 |
38.3% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
219 |
0 |
429 |
0 |
51.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
281 |
0 |
584 |
0 |
48.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
203 |
0 |
362 |
0 |
56.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
162 |
0 |
38.9% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
60 |
0 |
25.0% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
281 |
0 |
584 |
0 |
48.1% |
0 |
N/A |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.9718 |
0 |
0.9918 |
None |
140 |
0 |
140 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Alameda Health System |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.5713 |
0 |
0.6062 |
None |
647 |
0 |
1012 |
0 |
63.9% |
0 |
1 |
0 |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.6139 |
0 |
0 |
None |
20 |
0 |
41.706 |
0 |
0.4795 |
0 |
1 |
N/A |
Yes |
PY5 |
Alameda Health System |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
2.3771 |
0 |
0 |
None |
28 |
0 |
12.437 |
0 |
2.2513 |
0 |
0 |
N/A |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8922 |
0 |
0.8775 |
None |
113 |
0 |
121 |
0 |
93.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
Reported |
0.7636 |
0 |
0.7681 |
None |
107 |
0 |
121 |
0 |
88.4% |
0 |
N/A |
N/A |
NoS |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
Reported |
0.9091 |
0 |
0.9057 |
None |
115 |
0 |
121 |
0 |
95.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.5222 |
0 |
0.562 |
None |
165 |
0 |
207 |
0 |
79.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
â¶ Exclusive Breast Milk Feeding (PC-05) - -Black/African American |
Reported |
0.5077 |
0 |
0.5331 |
None |
40 |
0 |
68 |
0 |
58.8% |
0 |
0 |
0 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
â¶ Cesarean Birth (PC02-CH) - -Black/African American |
Reported |
0.2571 |
0 |
0.2481 |
None |
22 |
0 |
93 |
0 |
23.7% |
0 |
0 |
0 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2439 |
0 |
0.2415 |
None |
46 |
0 |
204 |
0 |
22.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.5269 |
0 |
0.5504 |
None |
198 |
0 |
299 |
0 |
66.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.0525 |
0 |
0.8634 |
None |
282 |
0 |
307 |
0 |
91.9% |
0 |
N/A |
N/A |
No |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
None |
2 |
0.4762 |
None |
133 |
0 |
147 |
0 |
90.5% |
0 |
N/A |
N/A |
No |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8119 |
0 |
0.8227 |
None |
177 |
0 |
205 |
0 |
86.3% |
0 |
1 |
0 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.3231 |
0 |
0.7133 |
None |
273 |
0 |
944 |
0 |
28.9% |
0 |
N/A |
N/A |
No |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.9954 |
0 |
0.9959 |
None |
169 |
0 |
169 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.6617 |
0 |
0.6875 |
None |
82 |
0 |
570 |
0 |
14.4% |
0 |
0 |
0 |
Yes |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.6617 |
0 |
0 |
None |
0.58 |
0 |
53.469 |
0 |
0.0108 |
0 |
N/A |
N/A |
No |
PY5 |
Antelope Valley Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.6391 |
0 |
0 |
None |
0 |
0 |
11.387 |
0 |
0 |
0 |
1 |
N/A |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0491 |
0 |
0.0848 |
None |
54 |
0 |
1240 |
0 |
4.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.418 |
0 |
0.5061 |
None |
2542 |
0 |
4610 |
0 |
55.1% |
0 |
1 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.217 |
0 |
0.6978 |
None |
137 |
0 |
186 |
0 |
73.7% |
0 |
1 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.3617 |
0 |
0.7637 |
None |
682 |
0 |
806 |
0 |
84.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.7455 |
0 |
0.7587 |
None |
21 |
0 |
None |
4 |
None |
4 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.5367 |
0 |
0.6667 |
None |
2916 |
0 |
3550 |
0 |
82.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.2947 |
0 |
0.3406 |
None |
185 |
0 |
553 |
0 |
33.5% |
0 |
1 |
N/A |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.2794 |
0 |
0.3406 |
None |
921 |
0 |
2544 |
0 |
36.2% |
0 |
0 |
N/A |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.282 |
0 |
0.3406 |
None |
1429 |
0 |
3923 |
0 |
36.4% |
0 |
0 |
N/A |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.3333 |
N/A |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
33 |
0 |
48.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
48 |
0 |
188 |
0 |
25.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
185 |
0 |
553 |
0 |
33.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
31 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
471 |
0 |
1124 |
0 |
41.9% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
697 |
0 |
1994 |
0 |
35.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1429 |
0 |
3923 |
0 |
36.4% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
921 |
0 |
2544 |
0 |
36.2% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
285 |
0 |
949 |
0 |
30.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
223 |
0 |
430 |
0 |
51.9% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1429 |
0 |
3923 |
0 |
36.4% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.5316 |
0 |
0.4676 |
None |
919 |
0 |
2762 |
0 |
33.3% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9944 |
0 |
0.78 |
None |
108 |
0 |
111 |
0 |
97.3% |
0 |
1 |
N/A |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.9912 |
0 |
N/A |
None |
187 |
0 |
2437 |
0 |
0.0767 |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
None |
None |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Immunizations for Adolescents - -Black/African American |
Reported |
None |
2 |
0.309 |
None |
None |
1 |
59 |
0 |
None |
1 |
0 |
0 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Child and Adolescent Well Care Visits - -Black/African American |
Reported |
0.4773 |
0 |
0.4915 |
None |
441 |
0 |
1190 |
0 |
37.1% |
0 |
0 |
0 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
None |
None |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1644 |
0 |
0.22 |
None |
117 |
0 |
600 |
0 |
19.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.7675 |
0 |
0.762 |
None |
239 |
0 |
315 |
0 |
75.9% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.6703 |
0 |
0.7111 |
None |
401 |
0 |
577 |
0 |
69.5% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
56 |
0 |
67.9% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
84 |
0 |
124 |
0 |
67.7% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
266 |
0 |
380 |
0 |
70.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
401 |
0 |
577 |
0 |
69.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
246 |
0 |
343 |
0 |
71.7% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
57 |
0 |
84 |
0 |
67.9% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
98 |
0 |
150 |
0 |
65.3% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
401 |
0 |
577 |
0 |
69.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8 |
0 |
0.8122 |
None |
367 |
0 |
577 |
0 |
63.6% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
39 |
0 |
56 |
0 |
69.6% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
80 |
0 |
124 |
0 |
64.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
240 |
0 |
380 |
0 |
63.2% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
367 |
0 |
577 |
0 |
63.6% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
210 |
0 |
343 |
0 |
61.2% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
84 |
0 |
59.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
107 |
0 |
150 |
0 |
71.3% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
367 |
0 |
577 |
0 |
63.6% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5007 |
0 |
0.5144 |
None |
1519 |
0 |
2460 |
0 |
61.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.2461 |
0 |
0.2933 |
None |
4295 |
0 |
13225 |
0 |
32.5% |
0 |
1 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.8808 |
0 |
0.8826 |
None |
13902 |
0 |
34900 |
0 |
39.8% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.6303 |
0 |
0.6466 |
None |
2931 |
0 |
4295 |
0 |
68.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.6474 |
0 |
0.6651 |
None |
2957 |
0 |
4295 |
0 |
68.9% |
0 |
1 |
0 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.7461 |
0 |
0.7587 |
None |
3407 |
0 |
4295 |
0 |
79.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.1553 |
0 |
0.4499 |
None |
167 |
0 |
307 |
0 |
54.4% |
0 |
1 |
0 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6542 |
0 |
0.6716 |
None |
393 |
0 |
645 |
0 |
60.9% |
0 |
0 |
0 |
YesS |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5483 |
0 |
0.5554 |
None |
3786 |
0 |
9701 |
0 |
39.0% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
105 |
0 |
246 |
0 |
42.7% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
441 |
0 |
1190 |
0 |
37.1% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
57 |
0 |
35.1% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
631 |
0 |
3190 |
0 |
19.8% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
2576 |
0 |
4995 |
0 |
51.6% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
3786 |
0 |
9701 |
0 |
39.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3039 |
0 |
6361 |
0 |
47.8% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
547 |
0 |
994 |
0 |
55.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
200 |
0 |
2346 |
0 |
8.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
3786 |
0 |
9701 |
0 |
39.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.2388 |
0 |
0.3187 |
None |
45 |
0 |
309 |
0 |
14.6% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
35 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
74 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
189 |
0 |
17.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
309 |
0 |
14.6% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
209 |
0 |
15.3% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
41 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
59 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
309 |
0 |
14.6% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.617 |
0 |
0.6215 |
None |
670 |
0 |
1160 |
0 |
57.8% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
None |
2 |
0.1765 |
None |
594 |
0 |
1541 |
0 |
38.6% |
0 |
1 |
1 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.1318 |
0 |
0.1813 |
None |
2723 |
0 |
16952 |
0 |
16.1% |
0 |
0.5 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.356 |
0 |
0.371 |
None |
163 |
0 |
469 |
0 |
34.8% |
0 |
0 |
0 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
59 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
64 |
0 |
37.5% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
128 |
0 |
333 |
0 |
38.4% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
163 |
0 |
469 |
0 |
34.8% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
127 |
0 |
253 |
0 |
50.2% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
40 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
176 |
0 |
15.3% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
163 |
0 |
469 |
0 |
34.8% |
0 |
N/A |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.8598 |
0 |
0.9918 |
None |
109 |
0 |
109 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.4177 |
0 |
0.58 |
None |
14 |
0 |
49.336 |
0 |
0.2838 |
0 |
1 |
N/A |
Yes |
PY5 |
Arrowhead Regional Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.7851 |
0 |
0.795 |
None |
11 |
0 |
13.252 |
0 |
0.8301 |
0 |
0 |
N/A |
Yes |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8533 |
0 |
0.86 |
None |
52 |
0 |
59 |
0 |
88.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.5599 |
0 |
0.5938 |
None |
836 |
0 |
1398 |
0 |
59.8% |
0 |
1 |
0 |
Yes |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.3462 |
0 |
0.6643 |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
None |
2 |
0.4499 |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Bear Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0514 |
0 |
0.0848 |
None |
58 |
0 |
1451 |
0 |
4.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.0161 |
0 |
0.0269 |
None |
15 |
0 |
1179 |
0 |
1.3% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6503 |
0 |
0.6521 |
None |
5327 |
0 |
8039 |
0 |
66.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8557 |
0 |
0.8621 |
None |
1055 |
0 |
1214 |
0 |
86.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8894 |
0 |
0.8925 |
None |
2449 |
0 |
2740 |
0 |
89.4% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8886 |
0 |
0.8775 |
None |
593 |
0 |
630 |
0 |
94.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7978 |
0 |
0.8018 |
None |
7029 |
0 |
8670 |
0 |
81.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.2922 |
0 |
0.3406 |
None |
359 |
0 |
1270 |
0 |
28.3% |
0 |
1 |
N/A |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3061 |
0 |
0.3406 |
None |
975 |
0 |
3128 |
0 |
31.2% |
0 |
1 |
N/A |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2731 |
0 |
0.3406 |
None |
2297 |
0 |
8269 |
0 |
27.8% |
0 |
1 |
N/A |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
35 |
0 |
37.1% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
271 |
0 |
1600 |
0 |
16.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
346 |
0 |
1225 |
0 |
28.2% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
135 |
0 |
37.0% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
529 |
0 |
1814 |
0 |
29.2% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
170 |
0 |
29.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1038 |
0 |
3290 |
0 |
31.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
2297 |
0 |
8269 |
0 |
27.8% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
965 |
0 |
3077 |
0 |
31.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1064 |
0 |
4173 |
0 |
25.5% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
268 |
0 |
1019 |
0 |
26.3% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
2297 |
0 |
8269 |
0 |
27.8% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.6504 |
0 |
0.6302 |
None |
5114 |
0 |
8269 |
0 |
61.9% |
0 |
0 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.5953 |
0 |
0.4676 |
None |
4989 |
0 |
8115 |
0 |
61.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8186 |
0 |
0.8204 |
None |
422 |
0 |
529 |
0 |
79.8% |
0 |
0 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.5719 |
0 |
0.5989 |
None |
427 |
0 |
670 |
0 |
63.7% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9918 |
0 |
0.78 |
None |
3258 |
0 |
3277 |
0 |
99.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.4297 |
0 |
0.4799 |
None |
5273 |
0 |
10290 |
0 |
51.2% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1731 |
0 |
0.22 |
None |
101 |
0 |
505 |
0 |
20.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.766 |
0 |
0.762 |
None |
1218 |
0 |
1598 |
0 |
76.2% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.9018 |
0 |
0.837 |
None |
926 |
0 |
981 |
0 |
94.4% |
0 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
104 |
0 |
108 |
0 |
96.3% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
110 |
0 |
123 |
0 |
89.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
179 |
0 |
190 |
0 |
94.2% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
499 |
0 |
521 |
0 |
95.8% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
926 |
0 |
981 |
0 |
94.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
506 |
0 |
527 |
0 |
96.0% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
379 |
0 |
408 |
0 |
92.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
41 |
0 |
46 |
0 |
89.1% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
926 |
0 |
981 |
0 |
94.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.9176 |
0 |
0.9181 |
None |
917 |
0 |
981 |
0 |
93.5% |
0 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
100 |
0 |
108 |
0 |
92.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
114 |
0 |
123 |
0 |
92.7% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
174 |
0 |
190 |
0 |
91.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
493 |
0 |
521 |
0 |
94.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
917 |
0 |
981 |
0 |
93.5% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
501 |
0 |
527 |
0 |
95.1% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
377 |
0 |
408 |
0 |
92.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
39 |
0 |
46 |
0 |
84.8% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
917 |
0 |
981 |
0 |
93.5% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.5379 |
0 |
0.4576 |
None |
548 |
0 |
1032 |
0 |
53.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9549 |
0 |
0.9434 |
None |
1696 |
0 |
1734 |
0 |
97.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.6991 |
0 |
0.6996 |
None |
149 |
0 |
188 |
0 |
79.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.8289 |
0 |
0.8282 |
None |
1162 |
0 |
1418 |
0 |
82.0% |
0 |
0 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.6477 |
0 |
0.6377 |
None |
6323 |
0 |
9422 |
0 |
67.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.5688 |
0 |
0.6131 |
None |
1008 |
0 |
1563 |
0 |
64.5% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.5232 |
0 |
0.5638 |
None |
26878 |
0 |
47513 |
0 |
56.6% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.86 |
0 |
0.7182 |
None |
27878 |
0 |
30336 |
0 |
91.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.9742 |
0 |
0.8988 |
None |
30973 |
0 |
31838 |
0 |
97.3% |
0 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9613 |
0 |
0 |
None |
42328 |
0 |
42677 |
0 |
99.2% |
0 |
N/A |
N/A |
YesI |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.4826 |
0 |
0.5263 |
None |
3696 |
0 |
6570 |
0 |
56.3% |
0 |
1 |
0 |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
None |
None |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.879 |
0 |
0.8864 |
None |
39476 |
0 |
42677 |
0 |
92.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.8524 |
0 |
0.8248 |
None |
15199 |
0 |
17753 |
0 |
85.6% |
0 |
1 |
N/A |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.8528 |
0 |
0.7932 |
None |
15152 |
0 |
17753 |
0 |
85.4% |
0 |
1 |
N/A |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.9154 |
0 |
0.8718 |
None |
16602 |
0 |
17753 |
0 |
93.5% |
0 |
1 |
N/A |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6883 |
0 |
0.7023 |
None |
1203 |
0 |
1608 |
0 |
74.8% |
0 |
1 |
1 |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.7797 |
0 |
0.6833 |
None |
551 |
0 |
696 |
0 |
79.2% |
0 |
1 |
1 |
YesS |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.6262 |
0 |
0.6316 |
None |
16904 |
0 |
26735 |
0 |
63.2% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5633 |
0 |
0.5689 |
None |
17492 |
0 |
30701 |
0 |
57.0% |
0 |
1 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
58 |
0 |
55.2% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
1559 |
0 |
2562 |
0 |
60.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
1877 |
0 |
3719 |
0 |
50.5% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
146 |
0 |
326 |
0 |
44.8% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
2522 |
0 |
4361 |
0 |
57.8% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
552 |
0 |
1028 |
0 |
53.7% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
10804 |
0 |
18647 |
0 |
57.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
17492 |
0 |
30701 |
0 |
57.0% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
10841 |
0 |
17587 |
0 |
61.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
5459 |
0 |
9508 |
0 |
57.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1192 |
0 |
3606 |
0 |
33.1% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
17492 |
0 |
30701 |
0 |
57.0% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.4373 |
0 |
0.4472 |
None |
630 |
0 |
1548 |
0 |
40.7% |
0 |
0 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
80 |
0 |
143 |
0 |
55.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
166 |
0 |
19.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
69 |
0 |
192 |
0 |
35.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
42 |
0 |
35.7% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
429 |
0 |
988 |
0 |
43.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
630 |
0 |
1548 |
0 |
40.7% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
392 |
0 |
818 |
0 |
47.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
189 |
0 |
536 |
0 |
35.3% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
49 |
0 |
194 |
0 |
25.3% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
630 |
0 |
1548 |
0 |
40.7% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6672 |
0 |
0.6615 |
None |
2321 |
0 |
3343 |
0 |
69.4% |
0 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5601 |
0 |
0.5646 |
None |
12419 |
0 |
22656 |
0 |
54.8% |
0 |
0 |
0 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.6909 |
0 |
0.3665 |
None |
2963 |
0 |
3787 |
0 |
78.2% |
0 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.821 |
0 |
0.6263 |
None |
30749 |
0 |
35150 |
0 |
87.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.4834 |
0 |
0.4857 |
None |
948 |
0 |
1593 |
0 |
59.5% |
0 |
1 |
1 |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
70 |
0 |
110 |
0 |
63.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
74 |
0 |
191 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
123 |
0 |
220 |
0 |
55.9% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
36 |
0 |
55.6% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
654 |
0 |
1021 |
0 |
64.1% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
948 |
0 |
1593 |
0 |
59.5% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
669 |
0 |
997 |
0 |
67.1% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
230 |
0 |
439 |
0 |
52.4% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
49 |
0 |
157 |
0 |
31.2% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
948 |
0 |
1593 |
0 |
59.5% |
0 |
N/A |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9853 |
0 |
0.92 |
None |
691 |
0 |
695 |
0 |
99.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.9842 |
0 |
0.92 |
None |
148 |
0 |
154 |
0 |
96.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Contra Costa Regional Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.2727 |
0 |
0.5004 |
None |
105 |
0 |
530 |
0 |
19.8% |
0 |
N/A |
N/A |
No |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.7698 |
0 |
0.7848 |
None |
108 |
0 |
135 |
0 |
80.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8843 |
0 |
0.8911 |
None |
484 |
0 |
533 |
0 |
90.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.944 |
0 |
0 |
None |
511 |
0 |
533 |
0 |
95.9% |
0 |
N/A |
N/A |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Eastern Plumas Health Care |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
â¶ Exclusive Breast Milk Feeding (PC-05) - -Asian |
Reported |
None |
2 |
0.4776 |
None |
21 |
0 |
46 |
0 |
45.7% |
0 |
0 |
0 |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.287 |
0 |
0.2481 |
None |
20 |
0 |
114 |
0 |
17.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.43 |
0 |
0.4776 |
None |
165 |
0 |
341 |
0 |
48.4% |
0 |
1 |
0 |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
1 |
0 |
0.837 |
None |
40 |
0 |
43 |
0 |
93.0% |
0 |
1 |
1 |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
40 |
0 |
43 |
0 |
93.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
36 |
0 |
94.4% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
40 |
0 |
43 |
0 |
93.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.7 |
0 |
0.7932 |
None |
33 |
0 |
43 |
0 |
76.7% |
0 |
N/A |
N/A |
No |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
43 |
0 |
76.7% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
36 |
0 |
77.8% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
43 |
0 |
76.7% |
0 |
N/A |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
None |
2 |
0.2258 |
None |
None |
1 |
34 |
0 |
None |
1 |
N/A |
N/A |
No |
PY5 |
El Camino Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.7684 |
0 |
0.7983 |
None |
69 |
0 |
73 |
0 |
94.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
83 |
0 |
83 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
El Camino Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Camino Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.4589 |
0 |
0 |
None |
43 |
0 |
65.16 |
0 |
0.6599 |
0 |
N/A |
N/A |
No |
PY5 |
El Camino Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.3912 |
0 |
0 |
None |
9 |
0 |
14.851 |
0 |
0.606 |
0 |
1 |
N/A |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6941 |
0 |
0.6679 |
None |
678 |
0 |
921 |
0 |
73.6% |
0 |
1 |
N/A |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.4211 |
0 |
0.7637 |
None |
120 |
0 |
155 |
0 |
77.4% |
0 |
1 |
0 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.6667 |
0 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.2707 |
0 |
0.3406 |
None |
173 |
0 |
617 |
0 |
28.0% |
0 |
1 |
N/A |
YesS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2793 |
0 |
0.3406 |
None |
177 |
0 |
658 |
0 |
26.9% |
0 |
1 |
N/A |
YesS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
173 |
0 |
621 |
0 |
27.9% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
177 |
0 |
658 |
0 |
26.9% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
173 |
0 |
617 |
0 |
28.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
37 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
177 |
0 |
658 |
0 |
26.9% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.1277 |
0 |
0.4501 |
None |
304 |
0 |
658 |
0 |
46.2% |
0 |
N/A |
N/A |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.4857 |
0 |
0.7983 |
None |
125 |
0 |
173 |
0 |
72.3% |
0 |
N/A |
N/A |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.6106 |
0 |
0.6133 |
None |
425 |
0 |
657 |
0 |
64.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.7536 |
0 |
0.7622 |
None |
38 |
0 |
63 |
0 |
60.3% |
0 |
N/A |
N/A |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.6918 |
0 |
0.7155 |
None |
2809 |
0 |
3866 |
0 |
72.7% |
0 |
1 |
0 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.2731 |
0 |
0.3176 |
None |
1914 |
0 |
5988 |
0 |
32.0% |
0 |
1 |
0 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.8583 |
0 |
0.8624 |
None |
5292 |
0 |
6013 |
0 |
88.0% |
0 |
1 |
1 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9401 |
0 |
0 |
None |
2790 |
0 |
2975 |
0 |
93.8% |
0 |
N/A |
N/A |
NoI |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.6287 |
0 |
0.6578 |
None |
59 |
0 |
281 |
0 |
21.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9019 |
0 |
0.907 |
None |
2627 |
0 |
2975 |
0 |
88.3% |
0 |
N/A |
N/A |
NoS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.8927 |
0 |
0.8248 |
None |
1332 |
0 |
1611 |
0 |
82.7% |
0 |
1 |
N/A |
YesS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.8927 |
0 |
0.7932 |
None |
1320 |
0 |
1611 |
0 |
81.9% |
0 |
1 |
N/A |
YesS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.899 |
0 |
0.8718 |
None |
1569 |
0 |
1611 |
0 |
97.4% |
0 |
1 |
N/A |
YesS |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.2248 |
0 |
0.518 |
None |
1174 |
0 |
1704 |
0 |
68.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5294 |
0 |
0.5384 |
None |
1435 |
0 |
1950 |
0 |
73.6% |
0 |
1 |
1 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
31 |
0 |
71.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1405 |
0 |
1908 |
0 |
73.6% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1435 |
0 |
1950 |
0 |
73.6% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1367 |
0 |
1846 |
0 |
74.1% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
43 |
0 |
49 |
0 |
87.8% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
55 |
0 |
45.5% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1435 |
0 |
1950 |
0 |
73.6% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.2459 |
0 |
0.3187 |
None |
24 |
0 |
74 |
0 |
32.4% |
0 |
1 |
0 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
72 |
0 |
30.6% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
74 |
0 |
32.4% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
68 |
0 |
32.4% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
74 |
0 |
32.4% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5079 |
0 |
0.5233 |
None |
54 |
0 |
130 |
0 |
41.5% |
0 |
N/A |
N/A |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.3265 |
0 |
0.3543 |
None |
710 |
0 |
1921 |
0 |
37.0% |
0 |
1 |
0 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3619 |
0 |
0.3763 |
None |
58 |
0 |
138 |
0 |
42.0% |
0 |
1 |
1 |
Yes |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
58 |
0 |
136 |
0 |
42.7% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
58 |
0 |
138 |
0 |
42.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
58 |
0 |
134 |
0 |
43.3% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
58 |
0 |
138 |
0 |
42.0% |
0 |
N/A |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.7755 |
0 |
0.79 |
None |
146 |
0 |
178 |
0 |
82.0% |
0 |
N/A |
N/A |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.3955 |
0 |
0 |
None |
13 |
0 |
18 |
0 |
0.7222 |
0 |
N/A |
N/A |
No |
PY5 |
El Centro Regional Medical Center |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6406 |
0 |
0.6433 |
None |
148 |
0 |
220 |
0 |
67.3% |
0 |
N/A |
N/A |
No |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3403 |
0 |
0.3406 |
None |
49 |
0 |
157 |
0 |
31.2% |
0 |
N/A |
N/A |
NoS |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3636 |
0 |
0.3613 |
None |
64 |
0 |
205 |
0 |
31.2% |
0 |
N/A |
N/A |
NoS |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
54 |
0 |
29.6% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
144 |
0 |
32.6% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
64 |
0 |
205 |
0 |
31.2% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
49 |
0 |
158 |
0 |
31.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
47 |
0 |
31.9% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
64 |
0 |
205 |
0 |
31.2% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2368 |
0 |
0.2351 |
None |
11 |
0 |
69 |
0 |
15.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.7114 |
0 |
0.7165 |
None |
196 |
0 |
270 |
0 |
72.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8 |
0 |
0.8037 |
None |
81 |
0 |
95 |
0 |
85.3% |
0 |
1 |
1 |
Yes |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
56 |
0 |
63 |
0 |
88.9% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
81 |
0 |
95 |
0 |
85.3% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
66 |
0 |
76 |
0 |
86.8% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
81 |
0 |
95 |
0 |
85.3% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8824 |
0 |
0.8864 |
None |
83 |
0 |
91 |
0 |
91.2% |
0 |
N/A |
N/A |
No |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
55 |
0 |
59 |
0 |
93.2% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
83 |
0 |
91 |
0 |
91.2% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
71 |
0 |
88.7% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
83 |
0 |
91 |
0 |
91.2% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.4328 |
0 |
0.4807 |
None |
87 |
0 |
145 |
0 |
60.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.2759 |
0 |
0.309 |
None |
25 |
0 |
54 |
0 |
46.3% |
0 |
1 |
1 |
Yes |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
34 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
54 |
0 |
46.3% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
43 |
0 |
51.2% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
54 |
0 |
46.3% |
0 |
N/A |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
1.8138 |
0 |
0.58 |
None |
1 |
0 |
3.281 |
0 |
0.3048 |
0 |
1 |
N/A |
Yes |
PY5 |
Hazel Hawkins Memorial Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.2321 |
0 |
0.4807 |
None |
20 |
0 |
43 |
0 |
46.5% |
0 |
0 |
0 |
Yes |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.3875 |
0 |
0.4955 |
None |
114 |
0 |
300 |
0 |
38.0% |
0 |
N/A |
N/A |
No |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
None |
2 |
0.5004 |
None |
76 |
0 |
265 |
0 |
28.7% |
0 |
N/A |
N/A |
No |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9834 |
0 |
0 |
None |
167 |
0 |
167 |
0 |
100.0% |
0 |
N/A |
N/A |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.8 |
0 |
0.812 |
None |
40 |
0 |
49 |
0 |
81.6% |
0 |
1 |
0 |
YesS |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9129 |
0 |
0.9169 |
None |
158 |
0 |
167 |
0 |
94.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.3846 |
0 |
0.518 |
None |
91 |
0 |
251 |
0 |
36.3% |
0 |
0 |
0 |
Yes |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.4322 |
0 |
0.4494 |
None |
63 |
0 |
202 |
0 |
31.2% |
0 |
0 |
0 |
Yes |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Jerold Phelps Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.4861 |
0 |
0.5061 |
None |
95 |
0 |
163 |
0 |
58.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.2581 |
0 |
0.518 |
None |
166 |
0 |
575 |
0 |
28.9% |
0 |
N/A |
N/A |
No |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.1741 |
0 |
0.3941 |
None |
155 |
0 |
624 |
0 |
24.8% |
0 |
N/A |
N/A |
No |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
93 |
0 |
307 |
0 |
30.3% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
49 |
0 |
281 |
0 |
17.4% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
155 |
0 |
624 |
0 |
24.8% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
30 |
0 |
79 |
0 |
38.0% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
174 |
0 |
25.9% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
80 |
0 |
371 |
0 |
21.6% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
155 |
0 |
624 |
0 |
24.8% |
0 |
N/A |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
None |
2 |
N/A |
None |
20 |
0 |
31 |
0 |
64.5% |
0 |
0 |
0 |
Yes |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0 |
0 |
0.1765 |
None |
0 |
0 |
43 |
0 |
0.0% |
0 |
0 |
0 |
Yes |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.1167 |
0 |
0.1677 |
None |
116 |
0 |
572 |
0 |
20.3% |
0 |
1 |
0 |
Yes |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
John C. Fremont Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.1384 |
0 |
0.133 |
None |
47 |
0 |
383 |
0 |
12.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
None |
2 |
0.1075 |
None |
None |
1 |
54 |
0 |
None |
1 |
1 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
None |
2 |
0.157 |
None |
None |
1 |
54 |
0 |
None |
1 |
0 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.7547 |
0 |
0.6679 |
None |
656 |
0 |
1005 |
0 |
65.3% |
0 |
0 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.6436 |
0 |
0.6667 |
None |
684 |
0 |
1116 |
0 |
61.3% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3617 |
0 |
0.3596 |
None |
163 |
0 |
567 |
0 |
28.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3492 |
None |
0.3483 |
None |
263 |
0 |
877 |
0 |
30.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
204 |
0 |
724 |
0 |
28.2% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
90 |
0 |
37.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
263 |
0 |
877 |
0 |
30.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
163 |
0 |
567 |
0 |
28.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
90 |
0 |
285 |
0 |
31.6% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
263 |
0 |
877 |
0 |
30.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.292 |
0 |
0.3096 |
None |
230 |
0 |
855 |
0 |
26.9% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.7224 |
0 |
0.7422 |
None |
3210 |
0 |
4968 |
0 |
64.6% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8406 |
0 |
0.837 |
None |
190 |
0 |
230 |
0 |
82.6% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
165 |
0 |
201 |
0 |
82.1% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
190 |
0 |
230 |
0 |
82.6% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
151 |
0 |
175 |
0 |
86.3% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
48 |
0 |
70.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
190 |
0 |
230 |
0 |
82.6% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8207 |
0 |
0.8308 |
None |
195 |
0 |
230 |
0 |
84.8% |
0 |
1 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
177 |
0 |
201 |
0 |
88.1% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
195 |
0 |
230 |
0 |
84.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
152 |
0 |
175 |
0 |
86.9% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
48 |
0 |
77.1% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
195 |
0 |
230 |
0 |
84.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5106 |
0 |
0.5233 |
None |
307 |
0 |
622 |
0 |
49.4% |
0 |
0 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.0378 |
0 |
0.126 |
None |
108 |
0 |
1985 |
0 |
5.4% |
0 |
0 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9591 |
0 |
0 |
None |
13313 |
0 |
13894 |
0 |
95.8% |
0 |
N/A |
N/A |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8176 |
0 |
0.8311 |
None |
11438 |
0 |
13894 |
0 |
82.3% |
0 |
0 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.303 |
0 |
0.5579 |
None |
1489 |
0 |
4154 |
0 |
35.8% |
0 |
0 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.3174 |
0 |
0.6107 |
None |
1444 |
0 |
4154 |
0 |
34.8% |
0 |
0 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.6697 |
0 |
0.6919 |
None |
2952 |
0 |
4154 |
0 |
71.1% |
0 |
1 |
0 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.3333 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.63 |
0 |
0.6353 |
None |
115 |
0 |
164 |
0 |
70.1% |
0 |
1 |
1 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6851 |
0 |
0.6994 |
None |
130 |
0 |
164 |
0 |
79.3% |
0 |
1 |
1 |
YesS |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
1 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5445 |
0 |
0.558 |
None |
1699 |
0 |
3217 |
0 |
52.8% |
0 |
0 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.6061 |
0 |
0.6075 |
None |
2750 |
0 |
5118 |
0 |
53.7% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
41 |
0 |
53.7% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
96 |
0 |
52.1% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
49 |
0 |
44.9% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
1415 |
0 |
2913 |
0 |
48.6% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1236 |
0 |
2008 |
0 |
61.6% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
2750 |
0 |
5118 |
0 |
53.7% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2144 |
0 |
3891 |
0 |
55.1% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
351 |
0 |
778 |
0 |
45.1% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
255 |
0 |
449 |
0 |
56.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
2750 |
0 |
5118 |
0 |
53.7% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.2911 |
0 |
0.3187 |
None |
63 |
0 |
319 |
0 |
19.8% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
182 |
0 |
17.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
120 |
0 |
23.3% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
319 |
0 |
19.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
55 |
0 |
254 |
0 |
21.7% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
39 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
319 |
0 |
19.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.3033 |
0 |
0.4829 |
None |
148 |
0 |
470 |
0 |
31.5% |
0 |
0 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.2168 |
0 |
0.2738 |
None |
1023 |
0 |
3347 |
0 |
30.6% |
0 |
1 |
0 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.2616 |
0 |
0.2981 |
None |
1908 |
0 |
5689 |
0 |
33.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3678 |
0 |
0.3816 |
None |
96 |
0 |
315 |
0 |
30.5% |
0 |
N/A |
N/A |
No |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
42 |
0 |
154 |
0 |
27.3% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
51 |
0 |
151 |
0 |
33.8% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
96 |
0 |
315 |
0 |
30.5% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
82 |
0 |
238 |
0 |
34.5% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
35 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
42 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
96 |
0 |
315 |
0 |
30.5% |
0 |
N/A |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kaweah Delta Health Care District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0275 |
0 |
0.0848 |
None |
22 |
0 |
543 |
0 |
4.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.0924 |
0 |
0.0984 |
None |
71 |
0 |
308 |
0 |
23.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.1338 |
0 |
0.1465 |
None |
97 |
0 |
308 |
0 |
31.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.3535 |
0 |
0.3851 |
None |
206 |
0 |
308 |
0 |
66.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
50 |
0 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
12 |
0 |
50 |
0 |
24.0% |
0 |
N/A |
N/A |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
24 |
0 |
50 |
0 |
48.0% |
0 |
N/A |
N/A |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0 |
0 |
0.0269 |
None |
None |
1 |
446 |
0 |
None |
1 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.564 |
0 |
0.5744 |
None |
1690 |
0 |
2925 |
0 |
57.8% |
0 |
1 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8817 |
0 |
0.8855 |
None |
193 |
0 |
217 |
0 |
88.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8908 |
0 |
0.8937 |
None |
324 |
0 |
350 |
0 |
92.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.9855 |
0 |
0.8775 |
None |
67 |
0 |
67 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7383 |
0 |
0.7483 |
None |
1984 |
0 |
2653 |
0 |
74.8% |
0 |
0.75 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.4396 |
0 |
0.4297 |
None |
89 |
0 |
240 |
0 |
37.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.4227 |
0 |
0.4145 |
None |
616 |
0 |
1669 |
0 |
36.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.4467 |
None |
0.4361 |
None |
1119 |
0 |
2724 |
0 |
41.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
80 |
0 |
25.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
85 |
0 |
226 |
0 |
37.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
762 |
0 |
2141 |
0 |
35.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
242 |
0 |
257 |
0 |
94.2% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1119 |
0 |
2724 |
0 |
41.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
616 |
0 |
1669 |
0 |
36.9% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
267 |
0 |
811 |
0 |
32.9% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
236 |
0 |
244 |
0 |
96.7% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1119 |
0 |
2724 |
0 |
41.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.2919 |
0 |
0.4501 |
None |
1307 |
0 |
2724 |
0 |
48.0% |
0 |
1 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.5292 |
0 |
0.4676 |
None |
1285 |
0 |
2660 |
0 |
48.3% |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.4727 |
0 |
0.5989 |
None |
131 |
0 |
183 |
0 |
71.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.8534 |
0 |
0.78 |
None |
961 |
0 |
1098 |
0 |
87.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
1.0146 |
0 |
0.998 |
None |
28 |
0 |
34.9038 |
0 |
0.8022 |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.8717 |
0 |
0.8765 |
None |
1370 |
0 |
1376 |
0 |
99.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Controlling High Blood Pressure (CBP) - -Black/African American |
Reported |
0.5138 |
0 |
0.5292 |
None |
157 |
0 |
295 |
0 |
53.2% |
0 |
1 |
0 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Exclusive Breast Milk Feeding (PC-05) - -Black/African American |
Reported |
0.4878 |
0 |
0.5152 |
None |
49 |
0 |
84 |
0 |
58.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6639 |
0 |
0.6737 |
None |
1154 |
0 |
1634 |
0 |
70.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.2971 |
0 |
0.7111 |
None |
484 |
0 |
678 |
0 |
71.4% |
0 |
1 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
183 |
0 |
252 |
0 |
72.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
279 |
0 |
393 |
0 |
71.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
484 |
0 |
678 |
0 |
71.4% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
157 |
0 |
209 |
0 |
75.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
75 |
0 |
61.3% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
281 |
0 |
394 |
0 |
71.3% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
484 |
0 |
678 |
0 |
71.4% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.3037 |
0 |
0.7932 |
None |
331 |
0 |
678 |
0 |
48.8% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
154 |
0 |
252 |
0 |
61.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
158 |
0 |
393 |
0 |
40.2% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
331 |
0 |
678 |
0 |
48.8% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
129 |
0 |
209 |
0 |
61.7% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
43 |
0 |
75 |
0 |
57.3% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
159 |
0 |
394 |
0 |
40.4% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
331 |
0 |
678 |
0 |
48.8% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9925 |
0 |
0.9434 |
None |
100 |
0 |
104 |
0 |
96.2% |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8755 |
0 |
0.8799 |
None |
235 |
0 |
238 |
0 |
98.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.6919 |
0 |
0.7133 |
None |
78 |
0 |
93 |
0 |
83.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.4485 |
0 |
0.4807 |
None |
1172 |
0 |
2165 |
0 |
54.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.4808 |
0 |
0.5256 |
None |
3565 |
0 |
10959 |
0 |
32.5% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.6296 |
0 |
0.6565 |
None |
7377 |
0 |
10281 |
0 |
71.8% |
0 |
1 |
1 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9821 |
0 |
0 |
None |
14447 |
0 |
14658 |
0 |
98.6% |
0 |
N/A |
N/A |
YesI |
PY5 |
Kern Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.2906 |
0 |
0.3535 |
None |
547 |
0 |
2082 |
0 |
26.3% |
0 |
0 |
0 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8684 |
0 |
0.8768 |
None |
12963 |
0 |
14658 |
0 |
88.4% |
0 |
1 |
0.25 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.1248 |
0 |
0.5579 |
None |
846 |
0 |
4396 |
0 |
19.2% |
0 |
0 |
0 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.152 |
0 |
0.6107 |
None |
946 |
0 |
4396 |
0 |
21.5% |
0 |
0 |
0 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.9721 |
0 |
0.8718 |
None |
4339 |
0 |
4396 |
0 |
98.7% |
0 |
1 |
N/A |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.3333 |
N/A |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.3363 |
0 |
0.6643 |
None |
240 |
0 |
635 |
0 |
37.8% |
0 |
0 |
0 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.3989 |
0 |
0.4499 |
None |
36 |
0 |
662 |
0 |
5.4% |
0 |
0 |
0 |
YesS |
PY5 |
Kern Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3358 |
0 |
0.3941 |
None |
4437 |
0 |
14694 |
0 |
30.2% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
81 |
0 |
132 |
0 |
61.4% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
270 |
0 |
673 |
0 |
40.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
3632 |
0 |
7922 |
0 |
45.9% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
443 |
0 |
5938 |
0 |
7.5% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
4437 |
0 |
14694 |
0 |
30.2% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3343 |
0 |
7196 |
0 |
46.5% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
695 |
0 |
1693 |
0 |
41.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
399 |
0 |
5805 |
0 |
6.9% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
4437 |
0 |
14694 |
0 |
30.2% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.2326 |
0 |
0.3187 |
None |
53 |
0 |
487 |
0 |
10.9% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
89 |
0 |
37.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
389 |
0 |
4.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
53 |
0 |
487 |
0 |
10.9% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
82 |
0 |
39.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
389 |
0 |
4.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
53 |
0 |
487 |
0 |
10.9% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.3707 |
0 |
0.4829 |
None |
623 |
0 |
1556 |
0 |
40.0% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.4515 |
0 |
0.4668 |
None |
2357 |
0 |
4984 |
0 |
47.3% |
0 |
1 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.0313 |
0 |
0.1765 |
None |
602 |
0 |
2542 |
0 |
23.7% |
0 |
1 |
1 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.4195 |
0 |
0.4402 |
None |
7034 |
0 |
14037 |
0 |
50.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.152 |
0 |
0.309 |
None |
62 |
0 |
682 |
0 |
9.1% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
81 |
0 |
19.8% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
43 |
0 |
592 |
0 |
7.3% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
682 |
0 |
9.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
76 |
0 |
21.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
42 |
0 |
590 |
0 |
7.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
682 |
0 |
9.1% |
0 |
N/A |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
92 |
0 |
92 |
0 |
100.0% |
0 |
1 |
0 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9051 |
0 |
0.9066 |
None |
1211 |
0 |
1296 |
0 |
93.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.8977 |
0 |
0.8999 |
None |
515 |
0 |
568 |
0 |
90.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.4842 |
0 |
0.795 |
None |
6 |
0 |
8.736 |
0 |
0.6868 |
0 |
1 |
N/A |
Yes |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
0.3406 |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.2917 |
0 |
0.3406 |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3056 |
0 |
0.3406 |
None |
20 |
0 |
78 |
0 |
25.6% |
0 |
1 |
N/A |
YesS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
69 |
0 |
24.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
78 |
0 |
25.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
60 |
0 |
21.7% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
78 |
0 |
25.6% |
0 |
N/A |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.2857 |
0 |
0.4807 |
None |
100 |
0 |
214 |
0 |
46.7% |
0 |
0 |
0 |
Yes |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.2469 |
0 |
0.4955 |
None |
397 |
0 |
758 |
0 |
52.4% |
0 |
1 |
0 |
Yes |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.2033 |
0 |
0.5579 |
None |
243 |
0 |
404 |
0 |
60.2% |
0 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.4856 |
0 |
0.6107 |
None |
289 |
0 |
404 |
0 |
71.5% |
0 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.9211 |
0 |
0.8718 |
None |
297 |
0 |
404 |
0 |
73.5% |
0 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
None |
2 |
0.6643 |
None |
13 |
0 |
30 |
0 |
43.3% |
0 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
None |
2 |
0.4499 |
None |
23 |
0 |
44 |
0 |
52.3% |
0 |
N/A |
N/A |
NoS |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.2743 |
0 |
0.3073 |
None |
176 |
0 |
453 |
0 |
38.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Kern Valley Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6162 |
0 |
0.6214 |
None |
204 |
0 |
371 |
0 |
55.0% |
0 |
N/A |
N/A |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3218 |
0 |
0.3406 |
None |
28 |
0 |
101 |
0 |
27.7% |
0 |
1 |
N/A |
YesS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3429 |
0 |
0.3427 |
None |
47 |
0 |
189 |
0 |
24.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
81 |
0 |
30.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
98 |
0 |
19.4% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
189 |
0 |
24.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
101 |
0 |
27.7% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
45 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
43 |
0 |
25.6% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
189 |
0 |
24.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.2179 |
0 |
0.2687 |
None |
71 |
0 |
245 |
0 |
29.0% |
0 |
1 |
0 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.3404 |
0 |
0.2481 |
None |
12 |
0 |
52 |
0 |
23.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.5938 |
0 |
0.7111 |
None |
38 |
0 |
48 |
0 |
79.2% |
0 |
1 |
1 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
31 |
0 |
87.1% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
48 |
0 |
79.2% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
30 |
0 |
83.3% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
48 |
0 |
79.2% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
41 |
0 |
90.2% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
41 |
0 |
90.2% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
None |
2 |
0.7932 |
None |
37 |
0 |
41 |
0 |
90.2% |
0 |
1 |
1 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5 |
0 |
0.5138 |
None |
196 |
0 |
307 |
0 |
63.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.3272 |
0 |
0.6131 |
None |
50 |
0 |
175 |
0 |
28.6% |
0 |
N/A |
N/A |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.2526 |
0 |
0.4955 |
None |
399 |
0 |
763 |
0 |
52.3% |
0 |
1 |
0 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.1967 |
0 |
0.2671 |
None |
623 |
0 |
2322 |
0 |
26.8% |
0 |
1 |
0 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.082 |
0 |
0.5579 |
None |
1352 |
0 |
1898 |
0 |
71.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.2123 |
0 |
0.6107 |
None |
1354 |
0 |
1898 |
0 |
71.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.7805 |
0 |
0.7896 |
None |
1780 |
0 |
1898 |
0 |
93.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.85 |
0 |
0.6833 |
None |
140 |
0 |
179 |
0 |
78.2% |
0 |
N/A |
N/A |
NoS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
None |
2 |
N/A |
None |
144 |
0 |
193 |
0 |
74.6% |
0 |
N/A |
N/A |
NoS |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.4063 |
0 |
0.518 |
None |
512 |
0 |
1060 |
0 |
48.3% |
0 |
N/A |
N/A |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5349 |
0 |
0.5434 |
None |
1424 |
0 |
2692 |
0 |
52.9% |
0 |
N/A |
N/A |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
32 |
0 |
53.1% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
30 |
0 |
43.3% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
70 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
685 |
0 |
1240 |
0 |
55.2% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
670 |
0 |
1312 |
0 |
51.1% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1424 |
0 |
2692 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1007 |
0 |
1740 |
0 |
57.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
178 |
0 |
368 |
0 |
48.4% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
239 |
0 |
584 |
0 |
40.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1424 |
0 |
2692 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.2901 |
0 |
0.3187 |
None |
34 |
0 |
175 |
0 |
19.4% |
0 |
N/A |
N/A |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
88 |
0 |
17.1% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
76 |
0 |
23.7% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
175 |
0 |
19.4% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
121 |
0 |
21.5% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
175 |
0 |
19.4% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.3885 |
0 |
0.4829 |
None |
26 |
0 |
195 |
0 |
13.3% |
0 |
N/A |
N/A |
No |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.5711 |
0 |
0.3665 |
None |
265 |
0 |
408 |
0 |
65.0% |
0 |
1 |
1 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.2425 |
0 |
0.2809 |
None |
590 |
0 |
1985 |
0 |
29.7% |
0 |
1 |
0 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.25 |
0 |
0.309 |
None |
45 |
0 |
137 |
0 |
32.9% |
0 |
1 |
0 |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
68 |
0 |
41.2% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
59 |
0 |
28.8% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
137 |
0 |
32.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
36 |
0 |
94 |
0 |
38.3% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
137 |
0 |
32.9% |
0 |
N/A |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.907 |
0 |
0 |
None |
2 |
0 |
4.75 |
0 |
0.4211 |
0 |
1 |
N/A |
Yes |
PY5 |
Lompoc Valley Medical Center |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0688 |
0 |
0.0848 |
None |
132 |
0 |
2039 |
0 |
6.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.1412 |
0 |
0.1423 |
None |
156 |
0 |
1098 |
0 |
14.2% |
0 |
0.75 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.2034 |
0 |
0.2092 |
None |
205 |
0 |
1098 |
0 |
18.7% |
0 |
0 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
12 |
0 |
71 |
0 |
16.9% |
0 |
N/A |
N/A |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
15 |
0 |
71 |
0 |
21.1% |
0 |
N/A |
N/A |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.3729 |
0 |
0 |
None |
37 |
0 |
71 |
0 |
52.1% |
0 |
N/A |
N/A |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.4896 |
0 |
0.5076 |
None |
454 |
0 |
1098 |
0 |
41.4% |
0 |
0 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.25 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.1533 |
0 |
0.161 |
None |
64 |
0 |
407 |
0 |
15.7% |
0 |
0.5 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.2403 |
0 |
0.2489 |
None |
112 |
0 |
407 |
0 |
27.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.75 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
Reported |
0.3522 |
None |
0.3894 |
None |
73 |
0 |
152 |
0 |
48.0% |
0 |
1 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
Reported |
0.2264 |
None |
0.2529 |
None |
53 |
0 |
152 |
0 |
34.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.5395 |
0 |
0.5523 |
None |
11431 |
0 |
19609 |
0 |
58.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.9248 |
0 |
0.9199 |
None |
4365 |
0 |
4660 |
0 |
93.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8946 |
0 |
0.8971 |
None |
7190 |
0 |
8006 |
0 |
89.8% |
0 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.9534 |
0 |
0.8775 |
None |
4126 |
0 |
4280 |
0 |
96.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7685 |
0 |
0.7755 |
None |
17183 |
0 |
21520 |
0 |
79.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.3772 |
0 |
0.3735 |
None |
984 |
0 |
2622 |
0 |
37.5% |
0 |
0.5 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3875 |
0 |
0.3828 |
None |
4657 |
0 |
12342 |
0 |
37.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3821 |
0 |
0.378 |
None |
7475 |
0 |
19677 |
0 |
38.0% |
0 |
0.5 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
48 |
0 |
124 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
356 |
0 |
1368 |
0 |
26.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
966 |
0 |
2573 |
0 |
37.5% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
29 |
0 |
63 |
0 |
46.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
312 |
0 |
785 |
0 |
39.8% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
56 |
0 |
142 |
0 |
39.4% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
5708 |
0 |
14622 |
0 |
39.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
7475 |
0 |
19677 |
0 |
38.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
4657 |
0 |
12342 |
0 |
37.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2280 |
0 |
6543 |
0 |
34.9% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
538 |
0 |
792 |
0 |
67.9% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
7475 |
0 |
19677 |
0 |
38.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5369 |
0 |
0.5462 |
None |
10783 |
0 |
19677 |
0 |
54.8% |
0 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.6025 |
0 |
0.4676 |
None |
9788 |
0 |
18562 |
0 |
52.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8341 |
0 |
0.8344 |
None |
3339 |
0 |
3997 |
0 |
83.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
Reported |
0.5604 |
0 |
0.636 |
None |
40 |
0 |
62 |
0 |
64.5% |
0 |
1 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
Reported |
0.7473 |
0 |
0.7872 |
None |
55 |
0 |
62 |
0 |
88.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.865 |
0 |
0.78 |
None |
9261 |
0 |
10177 |
0 |
91.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.9348 |
0 |
0.9199 |
None |
28939 |
0 |
30612 |
0 |
94.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Developmental Screening in the First Three Years of Life - -Black/African American |
Reported |
0.305 |
0 |
0.3112 |
None |
267 |
0 |
692 |
0 |
38.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Chlamydia Screening in Women (CHL) - -Asian |
Reported |
0.5486 |
0 |
0.5599 |
None |
108 |
0 |
164 |
0 |
65.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2601 |
0 |
0.2481 |
None |
213 |
0 |
948 |
0 |
22.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.5978 |
0 |
0.6142 |
None |
1175 |
0 |
2067 |
0 |
56.9% |
0 |
0 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7522 |
0 |
0.7607 |
None |
1479 |
0 |
1812 |
0 |
81.6% |
0 |
1 |
1 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
50 |
0 |
92.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
230 |
0 |
301 |
0 |
76.4% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
53 |
0 |
71 |
0 |
74.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
32 |
0 |
71.9% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1124 |
0 |
1353 |
0 |
83.1% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1479 |
0 |
1812 |
0 |
81.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
958 |
0 |
1119 |
0 |
85.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
470 |
0 |
606 |
0 |
77.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
51 |
0 |
87 |
0 |
58.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1479 |
0 |
1812 |
0 |
81.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8447 |
0 |
0.8524 |
None |
1491 |
0 |
1812 |
0 |
82.3% |
0 |
0 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
43 |
0 |
50 |
0 |
86.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
243 |
0 |
301 |
0 |
80.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
53 |
0 |
71 |
0 |
74.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
32 |
0 |
75.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1123 |
0 |
1353 |
0 |
83.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1491 |
0 |
1812 |
0 |
82.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
961 |
0 |
1119 |
0 |
85.9% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
490 |
0 |
606 |
0 |
80.9% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
40 |
0 |
87 |
0 |
46.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1491 |
0 |
1812 |
0 |
82.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9905 |
0 |
0.9434 |
None |
3835 |
0 |
3877 |
0 |
98.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.9286 |
0 |
0.7039 |
None |
180 |
0 |
198 |
0 |
90.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.8431 |
0 |
0.8282 |
None |
1991 |
0 |
2240 |
0 |
88.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5396 |
0 |
0.5494 |
None |
10827 |
0 |
19190 |
0 |
56.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.5752 |
0 |
0.6131 |
None |
1172 |
0 |
1889 |
0 |
62.0% |
0 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.9245 |
0 |
0.8988 |
None |
99174 |
0 |
108964 |
0 |
91.0% |
0 |
1 |
1 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.7218 |
0 |
0.7289 |
None |
13657 |
0 |
17950 |
0 |
76.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.7324 |
0 |
0.7416 |
None |
13926 |
0 |
17950 |
0 |
77.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.8205 |
0 |
0.8256 |
None |
16347 |
0 |
17950 |
0 |
91.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
N/A |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6261 |
0 |
0.6643 |
None |
1191 |
0 |
1792 |
0 |
66.5% |
0 |
1 |
0 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.6532 |
0 |
0.6562 |
None |
566 |
0 |
840 |
0 |
67.4% |
0 |
1 |
1 |
YesS |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
N/A |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3834 |
0 |
0.407 |
None |
16320 |
0 |
38233 |
0 |
42.7% |
0 |
1 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
70 |
0 |
44.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
426 |
0 |
1208 |
0 |
35.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
1326 |
0 |
3889 |
0 |
34.1% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
72 |
0 |
30.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
236 |
0 |
1034 |
0 |
22.8% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
159 |
0 |
351 |
0 |
45.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
14120 |
0 |
31609 |
0 |
44.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
16320 |
0 |
38233 |
0 |
42.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
12589 |
0 |
26377 |
0 |
47.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3003 |
0 |
7087 |
0 |
42.4% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
728 |
0 |
4769 |
0 |
15.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
16320 |
0 |
38233 |
0 |
42.7% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.4644 |
0 |
0.4716 |
None |
717 |
0 |
1836 |
0 |
39.1% |
0 |
0 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
55 |
0 |
56.4% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
57 |
0 |
242 |
0 |
23.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
64 |
0 |
40.6% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
597 |
0 |
1449 |
0 |
41.2% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
717 |
0 |
1836 |
0 |
39.1% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
501 |
0 |
1164 |
0 |
43.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
147 |
0 |
455 |
0 |
32.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
69 |
0 |
217 |
0 |
31.8% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
717 |
0 |
1836 |
0 |
39.1% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5977 |
0 |
0.6041 |
None |
3768 |
0 |
5629 |
0 |
66.9% |
0 |
1 |
1 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5865 |
0 |
0.5883 |
None |
44746 |
0 |
80641 |
0 |
55.5% |
0 |
0 |
0 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.5426 |
0 |
0.3665 |
None |
2015 |
0 |
4533 |
0 |
44.5% |
0 |
1 |
1 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.5489 |
0 |
0.5566 |
None |
51582 |
0 |
86124 |
0 |
59.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3901 |
0 |
0.4017 |
None |
135 |
0 |
323 |
0 |
41.8% |
0 |
1 |
1 |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
123 |
0 |
279 |
0 |
44.1% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
135 |
0 |
323 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
106 |
0 |
229 |
0 |
46.3% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
61 |
0 |
32.8% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
33 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
135 |
0 |
323 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9316 |
0 |
0.92 |
None |
7646 |
0 |
8026 |
0 |
95.3% |
0 |
1 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Los Angeles County Health System |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.5836 |
0 |
0 |
None |
117 |
0 |
183.619 |
0 |
0.6372 |
0 |
0 |
N/A |
Yes |
PY5 |
Los Angeles County Health System |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.418 |
0 |
0 |
None |
27 |
0 |
39.583 |
0 |
0.6821 |
0 |
1 |
N/A |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.5507 |
0 |
0.5624 |
None |
47 |
0 |
72 |
0 |
65.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.6667 |
0 |
0.6838 |
None |
48 |
0 |
66 |
0 |
72.7% |
0 |
1 |
0 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
None |
2 |
0.3406 |
None |
16 |
0 |
61 |
0 |
26.2% |
0 |
1 |
N/A |
YesS |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2459 |
0 |
0.3406 |
None |
26 |
0 |
90 |
0 |
28.9% |
0 |
1 |
N/A |
YesS |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
43 |
0 |
32.6% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
45 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
90 |
0 |
28.9% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
61 |
0 |
26.2% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
90 |
0 |
28.9% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.4775 |
0 |
0.4935 |
None |
74 |
0 |
124 |
0 |
59.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.5241 |
0 |
0.5646 |
None |
473 |
0 |
930 |
0 |
50.9% |
0 |
N/A |
N/A |
No |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.6699 |
0 |
0.6928 |
None |
757 |
0 |
879 |
0 |
86.1% |
0 |
N/A |
N/A |
No |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.1892 |
0 |
0.2623 |
None |
29 |
0 |
89 |
0 |
32.6% |
0 |
N/A |
N/A |
NoS |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9787 |
0 |
0 |
None |
821 |
0 |
833 |
0 |
98.6% |
0 |
N/A |
N/A |
NoI |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8953 |
0 |
0.901 |
None |
1028 |
0 |
1106 |
0 |
93.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.488 |
0 |
0.518 |
None |
266 |
0 |
481 |
0 |
55.3% |
0 |
1 |
0 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3914 |
0 |
0.4142 |
None |
513 |
0 |
1015 |
0 |
50.5% |
0 |
1 |
1 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
431 |
0 |
758 |
0 |
56.9% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
68 |
0 |
230 |
0 |
29.6% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
513 |
0 |
1015 |
0 |
50.5% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
400 |
0 |
699 |
0 |
57.2% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
110 |
0 |
263 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
53 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
513 |
0 |
1015 |
0 |
50.5% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.7813 |
0 |
0.5366 |
None |
27 |
0 |
39 |
0 |
69.2% |
0 |
1 |
1 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
38 |
0 |
71.1% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
39 |
0 |
69.2% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
39 |
0 |
69.2% |
0 |
N/A |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5472 |
0 |
0.5586 |
None |
40 |
0 |
85 |
0 |
47.1% |
0 |
N/A |
N/A |
No |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.4484 |
0 |
0.464 |
None |
170 |
0 |
285 |
0 |
59.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mammoth Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3503 |
0 |
0.3493 |
None |
94 |
0 |
303 |
0 |
31.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3556 |
0 |
0.3541 |
None |
124 |
0 |
424 |
0 |
29.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
60 |
0 |
30.0% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
97 |
0 |
322 |
0 |
30.1% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
124 |
0 |
424 |
0 |
29.3% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
94 |
0 |
303 |
0 |
31.0% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
29 |
0 |
115 |
0 |
25.2% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
124 |
0 |
424 |
0 |
29.3% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.6491 |
0 |
0.6622 |
None |
362 |
0 |
506 |
0 |
71.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.1579 |
0 |
0.4799 |
None |
253 |
0 |
793 |
0 |
31.9% |
0 |
N/A |
N/A |
No |
PY5 |
Marin General Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1667 |
0 |
0.22 |
None |
28 |
0 |
161 |
0 |
17.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.7597 |
0 |
0.7599 |
None |
107 |
0 |
139 |
0 |
77.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8973 |
0 |
0.837 |
None |
271 |
0 |
303 |
0 |
89.4% |
0 |
1 |
1 |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
246 |
0 |
261 |
0 |
94.3% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
271 |
0 |
303 |
0 |
89.4% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
238 |
0 |
252 |
0 |
94.4% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
49 |
0 |
65.3% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
271 |
0 |
303 |
0 |
89.4% |
0 |
N/A |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.608 |
0 |
0.611 |
None |
531 |
0 |
713 |
0 |
74.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.9815 |
0 |
0.9918 |
None |
23 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
No |
PY5 |
Marin General Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Marin General Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.7184 |
0 |
0.7386 |
None |
0 |
0 |
131 |
0 |
0.0% |
0 |
0 |
0 |
Yes |
PY5 |
Marin General Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.2134 |
0 |
0 |
None |
13 |
0 |
25.9 |
0 |
0.5019 |
0 |
N/A |
N/A |
No |
PY5 |
Marin General Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.8111 |
0 |
0.7182 |
None |
70 |
0 |
167 |
0 |
41.9% |
0 |
0 |
0 |
Yes |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0 |
0 |
0 |
None |
0 |
0 |
0.652 |
0 |
0 |
0 |
N/A |
N/A |
No |
PY5 |
Mayers Memorial Hospital District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.5823 |
0 |
0.614 |
None |
518 |
0 |
709 |
0 |
73.1% |
0 |
1 |
1 |
Yes |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9237 |
0 |
0 |
None |
555 |
0 |
560 |
0 |
99.1% |
0 |
N/A |
N/A |
NoI |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.6996 |
0 |
0.7216 |
None |
117 |
0 |
178 |
0 |
65.7% |
0 |
N/A |
N/A |
NoS |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8261 |
0 |
0.8387 |
None |
497 |
0 |
560 |
0 |
88.8% |
0 |
N/A |
N/A |
NoS |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Modoc Medical Center |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0387 |
0 |
0.0848 |
None |
17 |
0 |
507 |
0 |
3.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.0786 |
0 |
0.086 |
None |
37 |
0 |
305 |
0 |
12.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.1572 |
0 |
0.1676 |
None |
72 |
0 |
305 |
0 |
23.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
None |
1 |
60 |
0 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
12 |
0 |
60 |
0 |
20.0% |
0 |
N/A |
N/A |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.25 |
0 |
0 |
None |
25 |
0 |
60 |
0 |
41.7% |
0 |
N/A |
N/A |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.3974 |
0 |
0.4246 |
None |
145 |
0 |
305 |
0 |
47.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
None |
2 |
0.1075 |
None |
29 |
0 |
138 |
0 |
21.0% |
0 |
1 |
0 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
None |
2 |
0.071 |
None |
14 |
0 |
138 |
0 |
10.1% |
0 |
1 |
0 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6144 |
0 |
0.6198 |
None |
1339 |
0 |
2170 |
0 |
61.7% |
0 |
0.5 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.7831 |
0 |
0.7968 |
None |
137 |
0 |
168 |
0 |
81.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.7805 |
0 |
0.7944 |
None |
210 |
0 |
262 |
0 |
80.2% |
0 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8511 |
0 |
0.8537 |
None |
43 |
0 |
49 |
0 |
87.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7551 |
0 |
0.7634 |
None |
1060 |
0 |
1379 |
0 |
76.9% |
0 |
1 |
0.25 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.3571 |
0 |
0.3555 |
None |
12 |
0 |
42 |
0 |
28.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3722 |
0 |
0.369 |
None |
352 |
0 |
1071 |
0 |
32.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3439 |
0 |
0.3436 |
None |
496 |
0 |
1539 |
0 |
32.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
29 |
0 |
115 |
0 |
25.2% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
42 |
0 |
28.6% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
411 |
0 |
1242 |
0 |
33.1% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
36 |
0 |
122 |
0 |
29.5% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
496 |
0 |
1539 |
0 |
32.2% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
352 |
0 |
1071 |
0 |
32.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
106 |
0 |
332 |
0 |
31.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
136 |
0 |
27.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
496 |
0 |
1539 |
0 |
32.2% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5735 |
0 |
0.5792 |
None |
894 |
0 |
1539 |
0 |
58.1% |
0 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.3893 |
0 |
0.3971 |
None |
679 |
0 |
1666 |
0 |
40.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.7939 |
0 |
0.7982 |
None |
145 |
0 |
176 |
0 |
82.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.9945 |
0 |
0.7532 |
None |
68 |
0 |
69 |
0 |
98.6% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.3811 |
0 |
0.44 |
None |
890 |
0 |
1075 |
0 |
82.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.3333 |
0 |
0 |
None |
29 |
0 |
27.4682 |
0 |
1.0558 |
0 |
0 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2009 |
0 |
0.22 |
None |
101 |
0 |
471 |
0 |
21.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8508 |
0 |
0.837 |
None |
350 |
0 |
387 |
0 |
90.4% |
0 |
1 |
1 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
327 |
0 |
357 |
0 |
91.6% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
350 |
0 |
387 |
0 |
90.4% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
319 |
0 |
345 |
0 |
92.5% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
32 |
0 |
84.4% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
350 |
0 |
387 |
0 |
90.4% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8011 |
0 |
0.8132 |
None |
331 |
0 |
387 |
0 |
85.5% |
0 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
308 |
0 |
357 |
0 |
86.3% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
331 |
0 |
387 |
0 |
85.5% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
300 |
0 |
345 |
0 |
87.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
32 |
0 |
87.5% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
331 |
0 |
387 |
0 |
85.5% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.5776 |
0 |
0.4576 |
None |
355 |
0 |
613 |
0 |
57.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9955 |
0 |
0.9434 |
None |
3390 |
0 |
3432 |
0 |
98.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
1 |
0 |
0.7039 |
None |
191 |
0 |
195 |
0 |
98.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.924 |
0 |
0.8282 |
None |
210 |
0 |
232 |
0 |
90.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.505 |
0 |
0.5183 |
None |
1004 |
0 |
1791 |
0 |
56.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.7693 |
0 |
0.7763 |
None |
941 |
0 |
1142 |
0 |
82.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.4961 |
0 |
0.5394 |
None |
7022 |
0 |
17207 |
0 |
40.8% |
0 |
0 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.5841 |
0 |
0.5975 |
None |
15815 |
0 |
25296 |
0 |
62.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.6496 |
0 |
0.6745 |
None |
13387 |
0 |
17274 |
0 |
77.5% |
0 |
1 |
1 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9603 |
0 |
0 |
None |
12370 |
0 |
12780 |
0 |
96.8% |
0 |
N/A |
N/A |
YesI |
PY5 |
Natividad Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.5861 |
0 |
0.6195 |
None |
661 |
0 |
923 |
0 |
71.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9285 |
0 |
0.9309 |
None |
11985 |
0 |
12643 |
0 |
94.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.7786 |
0 |
0.7832 |
None |
10177 |
0 |
12559 |
0 |
81.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.7786 |
0 |
0.7801 |
None |
10184 |
0 |
12559 |
0 |
81.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.846 |
0 |
0.8486 |
None |
11395 |
0 |
12559 |
0 |
90.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.4613 |
0 |
0.4835 |
None |
160 |
0 |
226 |
0 |
70.8% |
0 |
1 |
1 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.5639 |
0 |
0.6643 |
None |
839 |
0 |
1235 |
0 |
67.9% |
0 |
1 |
0 |
YesS |
PY5 |
Natividad Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5492 |
0 |
0.5623 |
None |
4392 |
0 |
7806 |
0 |
56.3% |
0 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4808 |
0 |
0.4947 |
None |
14355 |
0 |
24607 |
0 |
58.3% |
0 |
1 |
1 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
71 |
0 |
66.2% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
267 |
0 |
570 |
0 |
46.8% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
180 |
0 |
426 |
0 |
42.3% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
81 |
0 |
45.7% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
12479 |
0 |
20446 |
0 |
61.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1345 |
0 |
3013 |
0 |
44.6% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
14355 |
0 |
24607 |
0 |
58.3% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
13158 |
0 |
21229 |
0 |
62.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1002 |
0 |
2345 |
0 |
42.7% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
195 |
0 |
1033 |
0 |
18.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
14355 |
0 |
24607 |
0 |
58.3% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.5437 |
0 |
0.5366 |
None |
620 |
0 |
1149 |
0 |
54.0% |
0 |
1 |
1 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
576 |
0 |
989 |
0 |
58.2% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
112 |
0 |
24.1% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
620 |
0 |
1149 |
0 |
54.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
567 |
0 |
962 |
0 |
58.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
40 |
0 |
99 |
0 |
40.4% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
88 |
0 |
14.8% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
620 |
0 |
1149 |
0 |
54.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5217 |
0 |
0.5357 |
None |
236 |
0 |
415 |
0 |
56.9% |
0 |
1 |
1 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.58 |
0 |
0.5825 |
None |
3047 |
0 |
5225 |
0 |
58.3% |
0 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.0075 |
0 |
0.1765 |
None |
76 |
0 |
2665 |
0 |
2.9% |
0 |
0 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.5626 |
0 |
0.569 |
None |
6878 |
0 |
11461 |
0 |
60.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.7939 |
0 |
0.5061 |
None |
819 |
0 |
1397 |
0 |
58.6% |
0 |
1 |
1 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
30 |
0 |
56.7% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
708 |
0 |
1162 |
0 |
60.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
82 |
0 |
167 |
0 |
49.1% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
819 |
0 |
1397 |
0 |
58.6% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
770 |
0 |
1235 |
0 |
62.4% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
43 |
0 |
127 |
0 |
33.9% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
35 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
819 |
0 |
1397 |
0 |
58.6% |
0 |
N/A |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9237 |
0 |
0.92 |
None |
694 |
0 |
738 |
0 |
94.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.8782 |
0 |
0.8824 |
None |
232 |
0 |
261 |
0 |
88.9% |
0 |
1 |
0 |
Yes |
PY5 |
Natividad Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Natividad Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6667 |
0 |
0.6762 |
None |
73 |
0 |
90 |
0 |
81.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.5882 |
0 |
0.7111 |
None |
27 |
0 |
36 |
0 |
75.0% |
0 |
1 |
0 |
Yes |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
36 |
0 |
75.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
36 |
0 |
75.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.5143 |
0 |
0.7932 |
None |
31 |
0 |
36 |
0 |
86.1% |
0 |
1 |
1 |
Yes |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
36 |
0 |
86.1% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
36 |
0 |
86.1% |
0 |
N/A |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.5188 |
0 |
0.3665 |
None |
55 |
0 |
130 |
0 |
42.3% |
0 |
N/A |
N/A |
No |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Northern Inyo Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.534 |
0 |
0.5474 |
None |
55 |
0 |
87 |
0 |
63.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.7337 |
0 |
0.7637 |
None |
41 |
0 |
53 |
0 |
77.4% |
0 |
1 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.6789 |
0 |
0.6948 |
None |
515 |
0 |
646 |
0 |
79.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.2706 |
0 |
0.3406 |
None |
33 |
0 |
129 |
0 |
25.6% |
0 |
1 |
N/A |
YesS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2864 |
0 |
0.3406 |
None |
68 |
0 |
255 |
0 |
26.7% |
0 |
1 |
N/A |
YesS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
101 |
0 |
26.7% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
143 |
0 |
26.6% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
68 |
0 |
255 |
0 |
26.7% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
129 |
0 |
25.6% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
81 |
0 |
32.1% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
45 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
68 |
0 |
255 |
0 |
26.7% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0 |
0 |
0.4501 |
None |
227 |
0 |
503 |
0 |
45.1% |
0 |
1 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.7076 |
0 |
0.4676 |
None |
73 |
0 |
271 |
0 |
26.9% |
0 |
0 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.6032 |
0 |
0.4576 |
None |
33 |
0 |
53 |
0 |
62.3% |
0 |
N/A |
N/A |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5323 |
0 |
0.5428 |
None |
186 |
0 |
342 |
0 |
54.4% |
0 |
1 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
None |
2 |
N/A |
None |
36 |
0 |
120 |
0 |
30.0% |
0 |
N/A |
N/A |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.1589 |
0 |
0.4955 |
None |
2186 |
0 |
4220 |
0 |
51.8% |
0 |
1 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.2106 |
0 |
0.2671 |
None |
754 |
0 |
3934 |
0 |
19.2% |
0 |
N/A |
N/A |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.7667 |
0 |
0.7799 |
None |
3065 |
0 |
4104 |
0 |
74.7% |
0 |
N/A |
N/A |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9758 |
0 |
0 |
None |
3448 |
0 |
3501 |
0 |
98.5% |
0 |
N/A |
N/A |
NoI |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.8605 |
0 |
0.8664 |
None |
395 |
0 |
478 |
0 |
82.6% |
0 |
N/A |
N/A |
NoS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9767 |
0 |
0.9525 |
None |
3300 |
0 |
3501 |
0 |
94.3% |
0 |
N/A |
N/A |
NoS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
None |
2 |
0.6919 |
None |
1505 |
0 |
1516 |
0 |
99.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
None |
2 |
0.6107 |
None |
971 |
0 |
1516 |
0 |
64.1% |
0 |
1 |
0 |
YesS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
None |
2 |
0.5579 |
None |
1015 |
0 |
1516 |
0 |
67.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5446 |
0 |
0.5581 |
None |
810 |
0 |
1437 |
0 |
56.4% |
0 |
1 |
0 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.2256 |
0 |
0.3941 |
None |
1042 |
0 |
2078 |
0 |
50.1% |
0 |
1 |
1 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
64 |
0 |
188 |
0 |
34.0% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
974 |
0 |
1879 |
0 |
51.8% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1042 |
0 |
2078 |
0 |
50.1% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
245 |
0 |
496 |
0 |
49.4% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
70 |
0 |
202 |
0 |
34.7% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
727 |
0 |
1380 |
0 |
52.7% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1042 |
0 |
2078 |
0 |
50.1% |
0 |
N/A |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
None |
2 |
N/A |
None |
83 |
0 |
200 |
0 |
41.5% |
0 |
N/A |
N/A |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5543 |
0 |
0.5593 |
None |
644 |
0 |
1145 |
0 |
56.2% |
0 |
1 |
0.25 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0 |
0 |
0.1765 |
None |
100 |
0 |
445 |
0 |
22.5% |
0 |
1 |
1 |
Yes |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.267 |
0 |
0.3029 |
None |
640 |
0 |
2506 |
0 |
25.5% |
0 |
N/A |
N/A |
No |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Oak Valley Hospital District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0 |
0 |
0.4799 |
None |
0 |
0 |
121 |
0 |
0.0% |
0 |
N/A |
N/A |
No |
PY5 |
Palo Verde Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
None |
2 |
0.4955 |
None |
102 |
0 |
503 |
0 |
20.3% |
0 |
0 |
0 |
Yes |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.6481 |
0 |
0.6551 |
None |
193 |
0 |
348 |
0 |
55.5% |
0 |
0 |
0 |
Yes |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.2718 |
0 |
0.5004 |
None |
140 |
0 |
505 |
0 |
27.7% |
0 |
N/A |
N/A |
No |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.209 |
0 |
0.7542 |
None |
36 |
0 |
390 |
0 |
9.2% |
0 |
0 |
0 |
YesS |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.8 |
0 |
0.812 |
None |
36 |
0 |
104 |
0 |
34.6% |
0 |
0 |
0 |
YesS |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9892 |
0 |
0 |
None |
390 |
0 |
390 |
0 |
100.0% |
0 |
N/A |
N/A |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palo Verde Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.7778 |
0 |
0.7878 |
None |
72 |
0 |
80 |
0 |
90.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.2584 |
0 |
0.3406 |
None |
38 |
0 |
145 |
0 |
26.2% |
0 |
1 |
N/A |
YesS |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.236 |
0 |
0.3406 |
None |
71 |
0 |
264 |
0 |
26.9% |
0 |
1 |
N/A |
YesS |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
47 |
0 |
153 |
0 |
30.7% |
0 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
84 |
0 |
25.0% |
0 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
71 |
0 |
264 |
0 |
26.9% |
0 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
145 |
0 |
26.2% |
0 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
82 |
0 |
28.1% |
0 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
37 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
71 |
0 |
264 |
0 |
26.9% |
0 |
N/A |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.3673 |
0 |
0.44 |
None |
154 |
0 |
300 |
0 |
51.3% |
0 |
1 |
0 |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
1 |
0 |
0.9199 |
None |
304 |
0 |
325 |
0 |
93.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1816 |
0 |
0.22 |
None |
119 |
0 |
670 |
0 |
17.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.484 |
0 |
0.5118 |
None |
321 |
0 |
625 |
0 |
51.4% |
0 |
1 |
0 |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8087 |
0 |
0.8198 |
None |
228 |
0 |
271 |
0 |
84.1% |
0 |
1 |
0 |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.3564 |
0 |
0.3812 |
None |
117 |
0 |
383 |
0 |
30.6% |
0 |
N/A |
N/A |
No |
PY5 |
Palomar Health |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Palomar Health |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.6129 |
0 |
0.9918 |
None |
305 |
0 |
374 |
0 |
81.6% |
0 |
N/A |
N/A |
No |
PY5 |
Palomar Health |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.988 |
0 |
0.92 |
None |
424 |
0 |
435 |
0 |
97.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.1758 |
0 |
0.4485 |
None |
198 |
0 |
206 |
0 |
96.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Palomar Health |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.3574 |
0 |
0 |
None |
29 |
0 |
46.933 |
0 |
0.6179 |
0 |
N/A |
N/A |
No |
PY5 |
Palomar Health |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.6867 |
0 |
0 |
None |
16 |
0 |
13.923 |
0 |
1.1492 |
0 |
N/A |
N/A |
No |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.4949 |
0 |
0.5122 |
None |
311 |
0 |
606 |
0 |
51.3% |
0 |
1 |
0 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0 |
0 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.5226 |
0 |
0.5044 |
None |
186 |
0 |
374 |
0 |
49.7% |
0 |
N/A |
N/A |
NoS |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.5114 |
0 |
0.4943 |
None |
234 |
0 |
447 |
0 |
52.4% |
0 |
N/A |
N/A |
NoS |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
202 |
0 |
399 |
0 |
50.6% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
47 |
0 |
66.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
234 |
0 |
447 |
0 |
52.4% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
186 |
0 |
374 |
0 |
49.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
47 |
0 |
66.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
234 |
0 |
447 |
0 |
52.4% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1865 |
0 |
0.22 |
None |
61 |
0 |
320 |
0 |
19.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.3409 |
0 |
0.4776 |
None |
281 |
0 |
837 |
0 |
33.6% |
0 |
N/A |
N/A |
No |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.545 |
0 |
0.5543 |
None |
216 |
0 |
372 |
0 |
58.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.1486 |
0 |
0.6131 |
None |
43 |
0 |
93 |
0 |
46.2% |
0 |
N/A |
N/A |
No |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.0974 |
0 |
0.5579 |
None |
49 |
0 |
1372 |
0 |
3.6% |
0 |
N/A |
N/A |
NoS |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.2322 |
0 |
0.6107 |
None |
179 |
0 |
1372 |
0 |
13.1% |
0 |
N/A |
N/A |
NoS |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.6273 |
0 |
0.6919 |
None |
694 |
0 |
1372 |
0 |
50.6% |
0 |
N/A |
N/A |
NoS |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5518 |
0 |
0.5646 |
None |
1214 |
0 |
2089 |
0 |
58.1% |
0 |
1 |
0 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3929 |
0 |
0.4156 |
None |
998 |
0 |
2352 |
0 |
42.4% |
0 |
1 |
0 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
928 |
0 |
2119 |
0 |
43.8% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
215 |
0 |
28.8% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
998 |
0 |
2352 |
0 |
42.4% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
904 |
0 |
2119 |
0 |
42.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
106 |
0 |
30.2% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
127 |
0 |
48.8% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
998 |
0 |
2352 |
0 |
42.4% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.3579 |
0 |
0.3758 |
None |
36 |
0 |
93 |
0 |
38.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
75 |
0 |
41.3% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
36 |
0 |
93 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
75 |
0 |
41.3% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
36 |
0 |
93 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5238 |
0 |
0.5376 |
None |
92 |
0 |
170 |
0 |
54.1% |
0 |
1 |
0 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3011 |
0 |
0.3216 |
None |
32 |
0 |
98 |
0 |
32.7% |
0 |
1 |
0 |
Yes |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
98 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
98 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
98 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
98 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Pioneers Memorial Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.2775 |
0 |
0.3941 |
None |
182 |
0 |
631 |
0 |
28.8% |
0 |
N/A |
N/A |
No |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
160 |
0 |
533 |
0 |
30.0% |
0 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
52 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
182 |
0 |
631 |
0 |
28.8% |
0 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
43 |
0 |
32.6% |
0 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
149 |
0 |
511 |
0 |
29.2% |
0 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
77 |
0 |
24.7% |
0 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
182 |
0 |
631 |
0 |
28.8% |
0 |
N/A |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.3968 |
0 |
0.4176 |
None |
142 |
0 |
337 |
0 |
42.1% |
0 |
1 |
0 |
Yes |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Plumas District Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0545 |
0 |
0.0848 |
None |
120 |
0 |
2440 |
0 |
4.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.1145 |
0 |
0.1183 |
None |
310 |
0 |
1363 |
0 |
22.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.1761 |
0 |
0.1846 |
None |
398 |
0 |
1363 |
0 |
29.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
12 |
0 |
91 |
0 |
13.2% |
0 |
N/A |
N/A |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
15 |
0 |
91 |
0 |
16.5% |
0 |
N/A |
N/A |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.2727 |
0 |
0 |
None |
25 |
0 |
91 |
0 |
27.5% |
0 |
N/A |
N/A |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.4513 |
0 |
0.4731 |
None |
767 |
0 |
1363 |
0 |
56.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.3087 |
0 |
0.2298 |
None |
57 |
0 |
166 |
0 |
34.3% |
0 |
1 |
N/A |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.4027 |
0 |
0.326 |
None |
84 |
0 |
166 |
0 |
50.6% |
0 |
1 |
N/A |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.0256 |
0 |
0.0269 |
None |
37 |
0 |
1393 |
0 |
2.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
Reported |
0.4776 |
None |
0.4975 |
None |
35 |
0 |
72 |
0 |
48.6% |
0 |
0 |
0 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
Reported |
0.2537 |
None |
0.2775 |
None |
16 |
0 |
72 |
0 |
22.2% |
0 |
0 |
0 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6101 |
0 |
0.6159 |
None |
255 |
0 |
407 |
0 |
62.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8024 |
0 |
0.8142 |
None |
1318 |
0 |
1535 |
0 |
85.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.7896 |
0 |
0.8026 |
None |
1777 |
0 |
2259 |
0 |
78.7% |
0 |
0 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8989 |
0 |
0.8775 |
None |
521 |
0 |
586 |
0 |
88.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.6903 |
0 |
0.7051 |
None |
5936 |
0 |
8393 |
0 |
70.7% |
0 |
1 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5945 |
0 |
0.5981 |
None |
4713 |
0 |
6792 |
0 |
69.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.4359 |
0 |
0.4391 |
None |
3311 |
0 |
7326 |
0 |
45.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8245 |
0 |
0.8258 |
None |
579 |
0 |
691 |
0 |
83.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9751 |
0 |
0.78 |
None |
2135 |
0 |
2355 |
0 |
90.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.6081 |
0 |
0.6393 |
None |
4171 |
0 |
5748 |
0 |
72.6% |
0 |
1 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 2 -Native Hawaiian/Pacific Islander |
Reported |
0.4242 |
0 |
0.4738 |
None |
43 |
0 |
46 |
0 |
93.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 3 -Native Hawaiian/Pacific Islander |
Reported |
0.7623 |
0 |
0.7813 |
None |
193 |
0 |
204 |
0 |
94.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 1 (informational only) -Native Hawaiian/Pacific Islander |
Reported |
0.877 |
0 |
0 |
None |
200 |
0 |
204 |
0 |
98.0% |
0 |
N/A |
0 |
YesI |
PY5 |
Riverside University Health System |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2125 |
0 |
0.22 |
None |
96 |
0 |
439 |
0 |
21.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6879 |
0 |
0.6953 |
None |
862 |
0 |
1231 |
0 |
70.0% |
0 |
1 |
0.25 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7211 |
0 |
0.7327 |
None |
1380 |
0 |
1763 |
0 |
78.3% |
0 |
1 |
1 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
37 |
0 |
75.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
97 |
0 |
145 |
0 |
66.9% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
749 |
0 |
956 |
0 |
78.4% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
495 |
0 |
608 |
0 |
81.4% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1380 |
0 |
1763 |
0 |
78.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
906 |
0 |
1120 |
0 |
80.9% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
277 |
0 |
397 |
0 |
69.8% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
197 |
0 |
246 |
0 |
80.1% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1380 |
0 |
1763 |
0 |
78.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.6135 |
0 |
0.7932 |
None |
1418 |
0 |
1763 |
0 |
80.4% |
0 |
1 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
37 |
0 |
89.2% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
132 |
0 |
145 |
0 |
91.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
803 |
0 |
956 |
0 |
84.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
436 |
0 |
608 |
0 |
71.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1418 |
0 |
1763 |
0 |
80.4% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
926 |
0 |
1120 |
0 |
82.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
340 |
0 |
397 |
0 |
85.6% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
152 |
0 |
246 |
0 |
61.8% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1418 |
0 |
1763 |
0 |
80.4% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
1 |
0 |
0.9434 |
None |
296 |
0 |
302 |
0 |
98.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.5111 |
0 |
0.5304 |
None |
71 |
0 |
105 |
0 |
67.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.5773 |
0 |
0.7983 |
None |
415 |
0 |
498 |
0 |
83.3% |
0 |
1 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.809 |
0 |
0.8109 |
None |
972 |
0 |
1134 |
0 |
85.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.4832 |
0 |
0.5067 |
None |
15725 |
0 |
26312 |
0 |
59.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.957 |
0 |
0.8988 |
None |
37326 |
0 |
38828 |
0 |
96.1% |
0 |
1 |
1 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.8939 |
0 |
0 |
None |
59013 |
0 |
59835 |
0 |
98.6% |
0 |
N/A |
N/A |
YesI |
PY5 |
Riverside University Health System |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.6231 |
0 |
0.6528 |
None |
8402 |
0 |
9239 |
0 |
90.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8541 |
0 |
0.8639 |
None |
57171 |
0 |
59552 |
0 |
96.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.7751 |
0 |
0.7801 |
None |
4803 |
0 |
5990 |
0 |
80.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.7767 |
0 |
0.7784 |
None |
4803 |
0 |
5990 |
0 |
80.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.8677 |
0 |
0.8681 |
None |
5212 |
0 |
5990 |
0 |
87.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.2376 |
0 |
0.4499 |
None |
58 |
0 |
196 |
0 |
29.6% |
0 |
0 |
0 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.4934 |
0 |
0.6643 |
None |
320 |
0 |
655 |
0 |
48.9% |
0 |
0 |
0 |
YesS |
PY5 |
Riverside University Health System |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3384 |
0 |
0.3941 |
None |
4762 |
0 |
18467 |
0 |
25.8% |
0 |
0 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
33 |
0 |
42.4% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
167 |
0 |
477 |
0 |
35.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
490 |
0 |
1626 |
0 |
30.1% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
65 |
0 |
29.2% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
3322 |
0 |
10161 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
46 |
0 |
28.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
737 |
0 |
6059 |
0 |
12.2% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
4762 |
0 |
18467 |
0 |
25.8% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3598 |
0 |
10408 |
0 |
34.6% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1023 |
0 |
3831 |
0 |
26.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
141 |
0 |
4228 |
0 |
3.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
4762 |
0 |
18467 |
0 |
25.8% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.1761 |
0 |
0.3187 |
None |
97 |
0 |
300 |
0 |
32.3% |
0 |
1 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
54 |
0 |
165 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
104 |
0 |
32.7% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
97 |
0 |
300 |
0 |
32.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
75 |
0 |
195 |
0 |
38.5% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
63 |
0 |
27.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
42 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
97 |
0 |
300 |
0 |
32.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6986 |
0 |
0.6615 |
None |
2215 |
0 |
3266 |
0 |
67.8% |
0 |
1 |
1 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.4586 |
0 |
0.4732 |
None |
10726 |
0 |
21813 |
0 |
49.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.2894 |
0 |
0.2971 |
None |
628 |
0 |
1611 |
0 |
39.0% |
0 |
1 |
1 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.7286 |
0 |
0.6263 |
None |
26374 |
0 |
39970 |
0 |
66.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.2052 |
0 |
0.309 |
None |
170 |
0 |
709 |
0 |
24.0% |
0 |
0 |
0 |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
75 |
0 |
20.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
113 |
0 |
426 |
0 |
26.5% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
182 |
0 |
20.3% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
170 |
0 |
709 |
0 |
24.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
139 |
0 |
433 |
0 |
32.1% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
162 |
0 |
14.8% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
114 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
170 |
0 |
709 |
0 |
24.0% |
0 |
N/A |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
63 |
0 |
63 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9844 |
0 |
0.92 |
None |
598 |
0 |
615 |
0 |
97.2% |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Riverside University Health System |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.5548 |
0 |
0.58 |
None |
25 |
0 |
50.942 |
0 |
0.4908 |
0 |
1 |
N/A |
Yes |
PY5 |
Riverside University Health System |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.1834 |
0 |
0.795 |
None |
3 |
0 |
14.494 |
0 |
0.207 |
0 |
1 |
N/A |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8939 |
0 |
0.8965 |
None |
521 |
0 |
560 |
0 |
93.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8646 |
0 |
0.8701 |
None |
1815 |
0 |
2055 |
0 |
88.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.7814 |
0 |
0.791 |
None |
262 |
0 |
329 |
0 |
79.6% |
0 |
1 |
0.25 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.3481 |
0 |
0.44 |
None |
180 |
0 |
360 |
0 |
50.0% |
0 |
1 |
0 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7135 |
0 |
0.7259 |
None |
176 |
0 |
197 |
0 |
89.3% |
0 |
1 |
1 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
60 |
0 |
69 |
0 |
87.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
91 |
0 |
101 |
0 |
90.1% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
176 |
0 |
197 |
0 |
89.3% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
153 |
0 |
172 |
0 |
89.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
176 |
0 |
197 |
0 |
89.3% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.7344 |
0 |
0.7932 |
None |
154 |
0 |
201 |
0 |
76.6% |
0 |
N/A |
N/A |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
54 |
0 |
71 |
0 |
76.1% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
79 |
0 |
103 |
0 |
76.7% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
154 |
0 |
201 |
0 |
76.6% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
137 |
0 |
176 |
0 |
77.8% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
154 |
0 |
201 |
0 |
76.6% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.922 |
0 |
0.9241 |
None |
690 |
0 |
745 |
0 |
92.6% |
0 |
1 |
0.25 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.4755 |
0 |
0.4917 |
None |
901 |
0 |
1347 |
0 |
66.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.284 |
0 |
0.4955 |
None |
8047 |
0 |
21844 |
0 |
36.8% |
0 |
N/A |
N/A |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.4517 |
0 |
0.4784 |
None |
8941 |
0 |
21052 |
0 |
42.5% |
0 |
N/A |
N/A |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.1288 |
0 |
0.5004 |
None |
7230 |
0 |
21006 |
0 |
34.4% |
0 |
N/A |
N/A |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.2031 |
0 |
0.2748 |
None |
493 |
0 |
1879 |
0 |
26.2% |
0 |
N/A |
N/A |
NoS |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9034 |
0 |
0 |
None |
19393 |
0 |
20924 |
0 |
92.7% |
0 |
N/A |
N/A |
NoI |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8213 |
0 |
0.8344 |
None |
18007 |
0 |
20924 |
0 |
86.1% |
0 |
N/A |
N/A |
NoS |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.4052 |
0 |
0.4499 |
None |
51 |
0 |
108 |
0 |
47.2% |
0 |
1 |
0 |
YesS |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6691 |
0 |
0.685 |
None |
119 |
0 |
160 |
0 |
74.4% |
0 |
1 |
1 |
YesS |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5685 |
0 |
0.5796 |
None |
4611 |
0 |
7234 |
0 |
63.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4279 |
0 |
0.4471 |
None |
1968 |
0 |
4063 |
0 |
48.4% |
0 |
1 |
1 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
137 |
0 |
334 |
0 |
41.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
59 |
0 |
18.6% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
588 |
0 |
1245 |
0 |
47.2% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
148 |
0 |
259 |
0 |
57.1% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1078 |
0 |
2141 |
0 |
50.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1968 |
0 |
4063 |
0 |
48.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1558 |
0 |
2890 |
0 |
53.9% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
376 |
0 |
1063 |
0 |
35.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
110 |
0 |
30.9% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1968 |
0 |
4063 |
0 |
48.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.3212 |
0 |
0.3427 |
None |
39 |
0 |
126 |
0 |
31.0% |
0 |
N/A |
N/A |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
38 |
0 |
29.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
44 |
0 |
25.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
39 |
0 |
126 |
0 |
31.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
105 |
0 |
32.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
39 |
0 |
126 |
0 |
31.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6291 |
0 |
0.6323 |
None |
708 |
0 |
1385 |
0 |
51.1% |
0 |
N/A |
N/A |
No |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.3241 |
0 |
0.3522 |
None |
2878 |
0 |
7233 |
0 |
39.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.21 |
0 |
0.2257 |
None |
159 |
0 |
289 |
0 |
55.0% |
0 |
1 |
1 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3457 |
0 |
0.3617 |
None |
82 |
0 |
197 |
0 |
41.6% |
0 |
1 |
1 |
Yes |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
56 |
0 |
30.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
115 |
0 |
53.9% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
82 |
0 |
197 |
0 |
41.6% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
75 |
0 |
133 |
0 |
56.4% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
60 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
82 |
0 |
197 |
0 |
41.6% |
0 |
N/A |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Salinas Valley Memorial Healthcare System |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.5825 |
0 |
0.591 |
None |
79 |
0 |
138 |
0 |
57.3% |
0 |
N/A |
N/A |
No |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5304 |
0 |
0.5411 |
None |
65 |
0 |
119 |
0 |
54.6% |
0 |
1 |
0 |
Yes |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.6575 |
0 |
0.6847 |
None |
884 |
0 |
1289 |
0 |
68.6% |
0 |
N/A |
N/A |
No |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.5188 |
0 |
0.5568 |
None |
1109 |
0 |
1330 |
0 |
83.4% |
0 |
1 |
1 |
Yes |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.373 |
0 |
0.3962 |
None |
281 |
0 |
571 |
0 |
49.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Bernardino Mountains Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0875 |
0 |
0.0872 |
None |
35 |
0 |
509 |
0 |
6.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.0324 |
0 |
0.0444 |
None |
50 |
0 |
877 |
0 |
5.7% |
0 |
1 |
0 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.0576 |
0 |
0.0962 |
None |
107 |
0 |
877 |
0 |
12.2% |
0 |
1 |
0 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.3022 |
0 |
0.3605 |
None |
341 |
0 |
877 |
0 |
38.9% |
0 |
1 |
0 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
0 |
0 |
0 |
None |
0 |
0 |
55 |
0 |
0.0% |
0 |
N/A |
N/A |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
None |
1 |
55 |
0 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.2182 |
0 |
0 |
None |
11 |
0 |
55 |
0 |
20.0% |
0 |
N/A |
N/A |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.568 |
0 |
0.578 |
None |
3149 |
0 |
5211 |
0 |
60.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8817 |
0 |
0.8855 |
None |
859 |
0 |
959 |
0 |
89.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8627 |
0 |
0.8684 |
None |
1703 |
0 |
1942 |
0 |
87.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8992 |
0 |
0.8775 |
None |
749 |
0 |
816 |
0 |
91.8% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7627 |
0 |
0.7702 |
None |
4027 |
0 |
4996 |
0 |
80.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.3112 |
0 |
0.3406 |
None |
276 |
0 |
815 |
0 |
33.9% |
0 |
1 |
N/A |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3643 |
0 |
0.3619 |
None |
441 |
0 |
1272 |
0 |
34.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2931 |
0 |
0.3406 |
None |
1180 |
0 |
4050 |
0 |
29.1% |
0 |
1 |
N/A |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
197 |
0 |
1149 |
0 |
17.2% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
276 |
0 |
815 |
0 |
33.9% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
87 |
0 |
36.8% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
152 |
0 |
492 |
0 |
30.9% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
74 |
0 |
215 |
0 |
34.4% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
445 |
0 |
1276 |
0 |
34.9% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1180 |
0 |
4050 |
0 |
29.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
441 |
0 |
1272 |
0 |
34.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
734 |
0 |
2757 |
0 |
26.6% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1180 |
0 |
4050 |
0 |
29.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5643 |
0 |
0.5709 |
None |
2495 |
0 |
4050 |
0 |
61.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.6451 |
0 |
0.4676 |
None |
2572 |
0 |
4033 |
0 |
63.8% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8446 |
0 |
0.837 |
None |
1846 |
0 |
2170 |
0 |
85.1% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.4641 |
0 |
0.5989 |
None |
213 |
0 |
437 |
0 |
48.7% |
0 |
0 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9878 |
0 |
0.78 |
None |
2794 |
0 |
2836 |
0 |
98.5% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Breast Cancer Screening (BCS) - -Black/African American |
Reported |
0.435 |
0 |
0.4807 |
None |
459 |
0 |
932 |
0 |
49.3% |
0 |
1 |
0 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Controlling High Blood Pressure (CBP) - -Black/African American |
Reported |
0.5093 |
0 |
0.5252 |
None |
669 |
0 |
1257 |
0 |
53.2% |
0 |
1 |
0 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2 |
0 |
0.22 |
None |
57 |
0 |
347 |
0 |
16.4% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.8288 |
0 |
0.762 |
None |
694 |
0 |
852 |
0 |
81.5% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8714 |
0 |
0.837 |
None |
315 |
0 |
370 |
0 |
85.1% |
0 |
1 |
1 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
51 |
0 |
69 |
0 |
73.9% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
31 |
0 |
77.4% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
197 |
0 |
222 |
0 |
88.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
315 |
0 |
370 |
0 |
85.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
176 |
0 |
195 |
0 |
90.3% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
138 |
0 |
172 |
0 |
80.2% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
315 |
0 |
370 |
0 |
85.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8457 |
0 |
0.8533 |
None |
321 |
0 |
370 |
0 |
86.8% |
0 |
1 |
1 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
58 |
0 |
69 |
0 |
84.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
31 |
0 |
77.4% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
197 |
0 |
222 |
0 |
88.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
321 |
0 |
370 |
0 |
86.8% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
175 |
0 |
195 |
0 |
89.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
144 |
0 |
172 |
0 |
83.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
321 |
0 |
370 |
0 |
86.8% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.5433 |
0 |
0.4576 |
None |
214 |
0 |
397 |
0 |
53.9% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9831 |
0 |
0.9434 |
None |
1103 |
0 |
1120 |
0 |
98.5% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
1 |
0 |
0.7039 |
None |
42 |
0 |
47 |
0 |
89.4% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8932 |
0 |
0.8959 |
None |
460 |
0 |
513 |
0 |
89.7% |
0 |
1 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.8439 |
0 |
0.8282 |
None |
288 |
0 |
347 |
0 |
83.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5055 |
0 |
0.5187 |
None |
3053 |
0 |
5444 |
0 |
56.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.8075 |
0 |
0.8107 |
None |
439 |
0 |
516 |
0 |
85.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.7053 |
0 |
0.7066 |
None |
20698 |
0 |
27589 |
0 |
75.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.6114 |
0 |
0.6401 |
None |
12488 |
0 |
20803 |
0 |
60.0% |
0 |
0 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9756 |
0 |
0 |
None |
33412 |
0 |
34227 |
0 |
97.6% |
0 |
N/A |
N/A |
YesI |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.7618 |
0 |
0.7776 |
None |
5843 |
0 |
7410 |
0 |
78.9% |
0 |
1 |
0.25 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.923 |
0 |
0.926 |
None |
31845 |
0 |
34227 |
0 |
93.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.25 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.6995 |
0 |
0.6833 |
None |
200 |
0 |
271 |
0 |
73.8% |
0 |
1 |
1 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.877 |
0 |
0.8282 |
None |
384 |
0 |
558 |
0 |
68.8% |
0 |
0 |
0 |
YesS |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.4762 |
0 |
0.518 |
None |
6238 |
0 |
13089 |
0 |
47.7% |
0 |
0 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4728 |
0 |
0.4875 |
None |
4703 |
0 |
10095 |
0 |
46.6% |
0 |
0 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
41 |
0 |
43.9% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
331 |
0 |
770 |
0 |
43.0% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
419 |
0 |
1052 |
0 |
39.8% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
51 |
0 |
130 |
0 |
39.2% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
138 |
0 |
344 |
0 |
40.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
263 |
0 |
541 |
0 |
48.6% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
3483 |
0 |
7217 |
0 |
48.3% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
4703 |
0 |
10095 |
0 |
46.6% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3473 |
0 |
6992 |
0 |
49.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1188 |
0 |
2919 |
0 |
40.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
42 |
0 |
184 |
0 |
22.8% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
4703 |
0 |
10095 |
0 |
46.6% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.4567 |
0 |
0.4647 |
None |
290 |
0 |
545 |
0 |
53.2% |
0 |
1 |
1 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
34 |
0 |
67.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
57 |
0 |
19.3% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
235 |
0 |
406 |
0 |
57.9% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
290 |
0 |
545 |
0 |
53.2% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
225 |
0 |
379 |
0 |
59.4% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
157 |
0 |
40.1% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
290 |
0 |
545 |
0 |
53.2% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.7419 |
0 |
0.6615 |
None |
740 |
0 |
993 |
0 |
74.5% |
0 |
1 |
1 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.6015 |
0 |
0.6018 |
None |
9459 |
0 |
15682 |
0 |
60.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.5666 |
0 |
0.3665 |
None |
1089 |
0 |
1576 |
0 |
69.1% |
0 |
1 |
1 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.8064 |
0 |
0.6263 |
None |
14469 |
0 |
17263 |
0 |
83.8% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.5854 |
0 |
0.5061 |
None |
319 |
0 |
536 |
0 |
59.5% |
0 |
1 |
1 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
31 |
0 |
67.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
68 |
0 |
33.8% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
251 |
0 |
394 |
0 |
63.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
319 |
0 |
536 |
0 |
59.5% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
254 |
0 |
381 |
0 |
66.7% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
149 |
0 |
41.6% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
319 |
0 |
536 |
0 |
59.5% |
0 |
N/A |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
162 |
0 |
162 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.8652 |
0 |
0.8707 |
None |
918 |
0 |
1017 |
0 |
90.3% |
0 |
1 |
0 |
Yes |
PY5 |
San Francisco General Hospital |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Francisco General Hospital |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8235 |
0 |
0.8331 |
None |
46 |
0 |
47 |
0 |
97.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.9425 |
0 |
0.9199 |
None |
58 |
0 |
59 |
0 |
98.3% |
0 |
1 |
N/A |
Yes |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
N/A |
No |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
1 |
0 |
0.92 |
None |
217 |
0 |
219 |
0 |
99.1% |
0 |
N/A |
N/A |
No |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.8512 |
0 |
0 |
None |
4 |
0 |
7.538 |
0 |
0.5306 |
0 |
0 |
N/A |
Yes |
PY5 |
San Gorgonio Memorial Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0507 |
0 |
0.0848 |
None |
11 |
0 |
533 |
0 |
2.1% |
0 |
1 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.0966 |
0 |
0.3605 |
None |
53 |
0 |
402 |
0 |
13.2% |
0 |
0 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
None |
2 |
0.0408 |
None |
None |
1 |
402 |
0 |
None |
1 |
0 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
None |
2 |
0.0962 |
None |
19 |
0 |
402 |
0 |
4.7% |
0 |
0 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.1194 |
0 |
0.1304 |
None |
None |
1 |
83 |
0 |
None |
1 |
0 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.2836 |
0 |
0.2878 |
None |
16 |
0 |
83 |
0 |
19.3% |
0 |
0 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.3855 |
0 |
0.5061 |
None |
1462 |
0 |
2533 |
0 |
57.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.7988 |
0 |
0.8109 |
None |
844 |
0 |
1035 |
0 |
81.6% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7875 |
0 |
0.7926 |
None |
1797 |
0 |
2255 |
0 |
79.7% |
0 |
1 |
0.25 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.4954 |
0 |
0.4799 |
None |
119 |
0 |
259 |
0 |
46.0% |
0 |
1 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.4986 |
0 |
0.4828 |
None |
369 |
0 |
848 |
0 |
43.5% |
0 |
1 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.4383 |
0 |
0.4285 |
None |
887 |
0 |
2265 |
0 |
39.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
124 |
0 |
498 |
0 |
24.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
119 |
0 |
259 |
0 |
46.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
197 |
0 |
439 |
0 |
44.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
428 |
0 |
1021 |
0 |
41.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
887 |
0 |
2265 |
0 |
39.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
369 |
0 |
848 |
0 |
43.5% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
462 |
0 |
1277 |
0 |
36.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
56 |
0 |
140 |
0 |
40.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
887 |
0 |
2265 |
0 |
39.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.3382 |
0 |
0.4501 |
None |
1039 |
0 |
2265 |
0 |
45.9% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.4783 |
0 |
0.773 |
None |
67 |
0 |
118 |
0 |
56.8% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.564 |
0 |
0.5989 |
None |
111 |
0 |
171 |
0 |
64.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.1404 |
0 |
0 |
None |
36 |
0 |
35.8662 |
0 |
1.0037 |
0 |
0 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.2185 |
0 |
0.4799 |
None |
304 |
0 |
2617 |
0 |
11.6% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Asthma Medication Ratio (AMR) - -White |
Reported |
0.5122 |
0 |
0.5989 |
None |
26 |
0 |
36 |
0 |
72.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Prenatal and Postpartum Care: Postpartum Care (PPC-PST) - -Black/African American |
Reported |
0.5 |
0 |
0.7111 |
None |
35 |
0 |
49 |
0 |
71.4% |
0 |
1 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1975 |
0 |
0.22 |
None |
77 |
0 |
482 |
0 |
16.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.7005 |
0 |
0.7067 |
None |
1056 |
0 |
1404 |
0 |
75.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.6084 |
0 |
0.7111 |
None |
266 |
0 |
341 |
0 |
78.0% |
0 |
1 |
1 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
33 |
0 |
38 |
0 |
86.8% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
49 |
0 |
71.4% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
46 |
0 |
82.6% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
156 |
0 |
201 |
0 |
77.6% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
266 |
0 |
341 |
0 |
78.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
148 |
0 |
189 |
0 |
78.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
109 |
0 |
141 |
0 |
77.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
266 |
0 |
341 |
0 |
78.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.7203 |
0 |
0.7932 |
None |
290 |
0 |
341 |
0 |
85.0% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
38 |
0 |
97.4% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
44 |
0 |
49 |
0 |
89.8% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
46 |
0 |
73.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
171 |
0 |
201 |
0 |
85.1% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
290 |
0 |
341 |
0 |
85.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
161 |
0 |
189 |
0 |
85.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
122 |
0 |
141 |
0 |
86.5% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
290 |
0 |
341 |
0 |
85.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9559 |
0 |
0.9434 |
None |
2227 |
0 |
2252 |
0 |
98.9% |
0 |
1 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.1912 |
0 |
0.7133 |
None |
593 |
0 |
689 |
0 |
86.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.421 |
0 |
0.4807 |
None |
1068 |
0 |
2462 |
0 |
43.4% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.5773 |
0 |
0.6131 |
None |
359 |
0 |
515 |
0 |
69.7% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.2128 |
0 |
0.4955 |
None |
4016 |
0 |
17216 |
0 |
23.3% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.4738 |
0 |
0.4982 |
None |
4927 |
0 |
21089 |
0 |
23.4% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.3785 |
0 |
0.5004 |
None |
9537 |
0 |
19031 |
0 |
50.1% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9221 |
0 |
0 |
None |
15673 |
0 |
16171 |
0 |
96.9% |
0 |
N/A |
N/A |
YesI |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.4503 |
0 |
0.4973 |
None |
1144 |
0 |
2260 |
0 |
50.6% |
0 |
1 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.835 |
0 |
0.8468 |
None |
14557 |
0 |
16171 |
0 |
90.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.7413 |
0 |
0.7497 |
None |
4193 |
0 |
5477 |
0 |
76.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.746 |
0 |
0.7507 |
None |
4234 |
0 |
5477 |
0 |
77.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.9181 |
0 |
0.8718 |
None |
5171 |
0 |
5477 |
0 |
94.4% |
0 |
1 |
N/A |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.4614 |
0 |
0.6643 |
None |
314 |
0 |
533 |
0 |
58.9% |
0 |
0 |
0 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.4931 |
0 |
0.5121 |
None |
30 |
0 |
40 |
0 |
75.0% |
0 |
1 |
1 |
YesS |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.2874 |
0 |
0.518 |
None |
4912 |
0 |
12441 |
0 |
39.5% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3859 |
0 |
0.4093 |
None |
5082 |
0 |
12308 |
0 |
41.3% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
30 |
0 |
46 |
0 |
65.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
467 |
0 |
888 |
0 |
52.6% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
683 |
0 |
1414 |
0 |
48.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
31 |
0 |
38.7% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
599 |
0 |
1304 |
0 |
45.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
96 |
0 |
194 |
0 |
49.5% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
3195 |
0 |
8431 |
0 |
37.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
5082 |
0 |
12308 |
0 |
41.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2247 |
0 |
4111 |
0 |
54.7% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2183 |
0 |
4545 |
0 |
48.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
652 |
0 |
3652 |
0 |
17.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
5082 |
0 |
12308 |
0 |
41.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.2274 |
0 |
0.3187 |
None |
193 |
0 |
515 |
0 |
37.5% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
42 |
0 |
54.8% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
66 |
0 |
27.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
63 |
0 |
33.3% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
123 |
0 |
320 |
0 |
38.4% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
193 |
0 |
515 |
0 |
37.5% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
113 |
0 |
252 |
0 |
44.8% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
156 |
0 |
32.1% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
30 |
0 |
107 |
0 |
28.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
193 |
0 |
515 |
0 |
37.5% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5359 |
0 |
0.5485 |
None |
393 |
0 |
715 |
0 |
55.0% |
0 |
1 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5221 |
0 |
0.5304 |
None |
2631 |
0 |
7359 |
0 |
35.8% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.6496 |
0 |
0.3665 |
None |
351 |
0 |
1183 |
0 |
29.7% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.3325 |
0 |
0.3619 |
None |
5849 |
0 |
11582 |
0 |
50.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3855 |
0 |
0.3976 |
None |
232 |
0 |
624 |
0 |
37.2% |
0 |
0 |
0 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
55 |
0 |
30.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
67 |
0 |
35.8% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
66 |
0 |
37.9% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
163 |
0 |
427 |
0 |
38.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
232 |
0 |
624 |
0 |
37.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
87 |
0 |
181 |
0 |
48.1% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
94 |
0 |
247 |
0 |
38.1% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
51 |
0 |
196 |
0 |
26.0% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
232 |
0 |
624 |
0 |
37.2% |
0 |
N/A |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
59 |
0 |
59 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.8802 |
0 |
0.8842 |
None |
220 |
0 |
239 |
0 |
92.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.3941 |
0 |
0 |
None |
8 |
0 |
20.039 |
0 |
0.3992 |
0 |
1 |
N/A |
Yes |
PY5 |
San Joaquin General Hospital |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
1.6829 |
0 |
0 |
None |
24 |
0 |
20.554 |
0 |
1.1677 |
0 |
0 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.1025 |
0 |
0.1007 |
None |
22 |
0 |
247 |
0 |
8.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.0724 |
0 |
0.0804 |
None |
29 |
0 |
576 |
0 |
5.0% |
0 |
0 |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.1095 |
0 |
0.1246 |
None |
60 |
0 |
576 |
0 |
10.4% |
0 |
0 |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.2783 |
0 |
0.3605 |
None |
174 |
0 |
576 |
0 |
30.2% |
0 |
0 |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
None |
1 |
125 |
0 |
None |
1 |
N/A |
0 |
YesI |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
0 |
None |
None |
1 |
125 |
0 |
None |
1 |
N/A |
0 |
YesI |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.176 |
0 |
0 |
None |
17 |
0 |
125 |
0 |
13.6% |
0 |
N/A |
0 |
YesI |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.5187 |
0 |
0.5336 |
None |
1728 |
0 |
2794 |
0 |
61.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8521 |
0 |
0.8589 |
None |
257 |
0 |
288 |
0 |
89.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.9568 |
0 |
0.9199 |
None |
516 |
0 |
546 |
0 |
94.5% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8529 |
0 |
0.8554 |
None |
32 |
0 |
32 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7612 |
0 |
0.7689 |
None |
2824 |
0 |
3533 |
0 |
79.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.337 |
None |
0.3406 |
None |
31 |
0 |
95 |
0 |
32.6% |
0 |
1 |
N/A |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3357 |
None |
0.3406 |
None |
290 |
0 |
878 |
0 |
33.0% |
0 |
1 |
N/A |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2857 |
None |
0.3406 |
None |
587 |
0 |
2012 |
0 |
29.2% |
0 |
1 |
N/A |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
45 |
0 |
31.1% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
48 |
0 |
254 |
0 |
18.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
95 |
0 |
32.6% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
80 |
0 |
33.8% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
229 |
0 |
754 |
0 |
30.4% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
238 |
0 |
783 |
0 |
30.4% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
587 |
0 |
2012 |
0 |
29.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
290 |
0 |
878 |
0 |
33.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
246 |
0 |
951 |
0 |
25.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
51 |
0 |
183 |
0 |
27.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
587 |
0 |
2012 |
0 |
29.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.6178 |
0 |
0.619 |
None |
1260 |
0 |
2012 |
0 |
62.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.6319 |
0 |
0.4676 |
None |
1323 |
0 |
2196 |
0 |
60.3% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.7665 |
0 |
0.7736 |
None |
268 |
0 |
325 |
0 |
82.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.8571 |
0 |
0.7532 |
None |
45 |
0 |
52 |
0 |
86.5% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.5452 |
0 |
0.5687 |
None |
193 |
0 |
327 |
0 |
59.0% |
0 |
1 |
0.25 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.639 |
0 |
0 |
None |
12 |
0 |
19.5411 |
0 |
0.6141 |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Breast Cancer Screening (BCS) - -Black/African American |
Reported |
0.587 |
0 |
0.5921 |
None |
34 |
0 |
57 |
0 |
59.7% |
0 |
1 |
0.25 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.25 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 2 -Black/African American |
Reported |
0.6083 |
0 |
None |
None |
76 |
0 |
114 |
0 |
66.7% |
0 |
0 |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 3 -Black/African American |
Reported |
0.8595 |
0 |
None |
None |
296 |
0 |
338 |
0 |
87.6% |
0 |
1 |
0.25 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 1 (informational only) -Black/African American |
Reported |
0.989 |
0 |
0 |
None |
336 |
0 |
341 |
0 |
98.5% |
0 |
N/A |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.9457 |
0 |
0.837 |
None |
247 |
0 |
265 |
0 |
93.2% |
0 |
1 |
1 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
126 |
0 |
131 |
0 |
96.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
100 |
0 |
112 |
0 |
89.3% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
247 |
0 |
265 |
0 |
93.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
177 |
0 |
191 |
0 |
92.7% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
41 |
0 |
92.7% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
33 |
0 |
97.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
247 |
0 |
265 |
0 |
93.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8806 |
0 |
0.8848 |
None |
198 |
0 |
218 |
0 |
90.8% |
0 |
1 |
1 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
96 |
0 |
108 |
0 |
88.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
88 |
0 |
95 |
0 |
92.6% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
198 |
0 |
218 |
0 |
90.8% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
149 |
0 |
162 |
0 |
92.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
30 |
0 |
90.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
198 |
0 |
218 |
0 |
90.8% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.5556 |
0 |
0.4576 |
None |
45 |
0 |
79 |
0 |
57.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
1 |
0 |
0.9434 |
None |
788 |
0 |
788 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8268 |
0 |
0.8361 |
None |
114 |
0 |
127 |
0 |
89.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.9096 |
0 |
0.8282 |
None |
88 |
0 |
99 |
0 |
88.9% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.7123 |
0 |
0.6377 |
None |
1181 |
0 |
1848 |
0 |
63.9% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.9371 |
0 |
0.8394 |
None |
244 |
0 |
350 |
0 |
69.7% |
0 |
0 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.3104 |
0 |
0.4955 |
None |
9809 |
0 |
21694 |
0 |
45.2% |
0 |
0 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.644 |
0 |
0.6514 |
None |
9024 |
0 |
13867 |
0 |
65.1% |
0 |
0.75 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.5884 |
0 |
0.6194 |
None |
13173 |
0 |
22271 |
0 |
59.2% |
0 |
0 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9928 |
0 |
0 |
None |
11610 |
0 |
11698 |
0 |
99.3% |
0 |
N/A |
N/A |
YesI |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.4665 |
0 |
0.5118 |
None |
977 |
0 |
1596 |
0 |
61.2% |
0 |
1 |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9137 |
0 |
0.9176 |
None |
10980 |
0 |
11698 |
0 |
93.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.1699 |
0 |
0.5579 |
None |
6056 |
0 |
7357 |
0 |
82.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.8675 |
0 |
0.8248 |
None |
6177 |
0 |
7357 |
0 |
84.0% |
0 |
1 |
N/A |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.8943 |
0 |
0.8718 |
None |
6580 |
0 |
7357 |
0 |
89.4% |
0 |
1 |
N/A |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.622 |
0 |
0.6281 |
None |
118 |
0 |
155 |
0 |
76.1% |
0 |
1 |
1 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.8542 |
0 |
0.8282 |
None |
356 |
0 |
443 |
0 |
80.4% |
0 |
0 |
0 |
YesS |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.692 |
0 |
0.6799 |
None |
3301 |
0 |
5650 |
0 |
58.4% |
0 |
0 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.7747 |
0 |
0.6197 |
None |
7079 |
0 |
12292 |
0 |
57.6% |
0 |
0 |
0 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
104 |
0 |
48.1% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
209 |
0 |
347 |
0 |
60.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
78 |
0 |
57.7% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
72 |
0 |
131 |
0 |
55.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
3654 |
0 |
6019 |
0 |
60.7% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
3040 |
0 |
5600 |
0 |
54.3% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
7079 |
0 |
12292 |
0 |
57.6% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
5764 |
0 |
9791 |
0 |
58.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
767 |
0 |
1371 |
0 |
55.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
548 |
0 |
1130 |
0 |
48.5% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
7079 |
0 |
12292 |
0 |
57.6% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.7016 |
0 |
0.5366 |
None |
211 |
0 |
350 |
0 |
60.3% |
0 |
1 |
1 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
86 |
0 |
58.1% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
158 |
0 |
254 |
0 |
62.2% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
211 |
0 |
350 |
0 |
60.3% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
118 |
0 |
179 |
0 |
65.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
75 |
0 |
142 |
0 |
52.8% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
211 |
0 |
350 |
0 |
60.3% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.798 |
0 |
0.6615 |
None |
1023 |
0 |
1333 |
0 |
76.7% |
0 |
1 |
1 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5774 |
0 |
0.5801 |
None |
5116 |
0 |
8534 |
0 |
60.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.6369 |
0 |
0.3665 |
None |
619 |
0 |
843 |
0 |
73.4% |
0 |
1 |
1 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.6769 |
0 |
0.6263 |
None |
7005 |
0 |
9799 |
0 |
71.5% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.5663 |
0 |
0.5061 |
None |
344 |
0 |
663 |
0 |
51.9% |
0 |
1 |
1 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
114 |
0 |
231 |
0 |
49.4% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
211 |
0 |
409 |
0 |
51.6% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
344 |
0 |
663 |
0 |
51.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
287 |
0 |
546 |
0 |
52.6% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
65 |
0 |
53.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
52 |
0 |
42.3% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
344 |
0 |
663 |
0 |
51.9% |
0 |
N/A |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9947 |
0 |
0.92 |
None |
409 |
0 |
409 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.6933 |
0 |
0.716 |
None |
60 |
0 |
66 |
0 |
90.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
San Mateo Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
San Mateo Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0955 |
0 |
0.0944 |
None |
78 |
0 |
803 |
0 |
9.7% |
0 |
0 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.0575 |
0 |
0.067 |
None |
30 |
0 |
575 |
0 |
5.2% |
0 |
0 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.0887 |
0 |
0.1059 |
None |
64 |
0 |
575 |
0 |
11.1% |
0 |
1 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.2397 |
0 |
0.3605 |
None |
223 |
0 |
575 |
0 |
38.8% |
0 |
1 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.0981 |
0 |
0.1113 |
None |
60 |
0 |
410 |
0 |
14.6% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.2344 |
0 |
0.2436 |
None |
116 |
0 |
410 |
0 |
28.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
Reported |
0.3669 |
0 |
0.3979 |
None |
58 |
0 |
162 |
0 |
35.8% |
0 |
0 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
Reported |
0.3669 |
0 |
0.3793 |
None |
19 |
0 |
162 |
0 |
11.7% |
0 |
0 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.4671 |
0 |
0.5061 |
None |
3768 |
0 |
7357 |
0 |
51.2% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.6836 |
0 |
0.6991 |
None |
4957 |
0 |
6995 |
0 |
70.9% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.3612 |
0 |
0.3591 |
None |
154 |
0 |
476 |
0 |
32.4% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.422 |
0 |
0.4139 |
None |
1196 |
0 |
3203 |
0 |
37.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3426 |
0 |
0.3424 |
None |
2285 |
0 |
7429 |
0 |
30.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
38 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
420 |
0 |
2134 |
0 |
19.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
145 |
0 |
455 |
0 |
31.9% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
65 |
0 |
30.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
1528 |
0 |
4320 |
0 |
35.4% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
199 |
0 |
31.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
99 |
0 |
218 |
0 |
45.4% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
2285 |
0 |
7429 |
0 |
30.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1198 |
0 |
3211 |
0 |
37.3% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1026 |
0 |
4091 |
0 |
25.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
61 |
0 |
127 |
0 |
48.0% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
2285 |
0 |
7429 |
0 |
30.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.4834 |
0 |
0.4676 |
None |
4323 |
0 |
7467 |
0 |
57.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8176 |
0 |
0.8195 |
None |
772 |
0 |
880 |
0 |
87.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
Reported |
0.6203 |
0 |
0.6391 |
None |
84 |
0 |
122 |
0 |
68.9% |
0 |
1 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
Reported |
0.8354 |
0 |
0.8424 |
None |
111 |
0 |
122 |
0 |
91.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9789 |
0 |
0.78 |
None |
4503 |
0 |
4505 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Prenatal and Postpartum Care: Postpartum Care (PPC-PST) - -Black/African American |
Reported |
0.661 |
0 |
0.7111 |
None |
51 |
0 |
66 |
0 |
77.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Colorectal Cancer Screening - -Black/African American |
Reported |
0.5152 |
0 |
0.5241 |
None |
650 |
0 |
1183 |
0 |
55.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2033 |
0 |
0.22 |
None |
207 |
0 |
1078 |
0 |
19.2% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.7036 |
0 |
0.7094 |
None |
2216 |
0 |
3189 |
0 |
69.5% |
0 |
0 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7613 |
0 |
0.7689 |
None |
803 |
0 |
1022 |
0 |
78.6% |
0 |
1 |
1 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
108 |
0 |
120 |
0 |
90.0% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
44 |
0 |
58 |
0 |
75.9% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
611 |
0 |
784 |
0 |
77.9% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
803 |
0 |
1022 |
0 |
78.6% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
558 |
0 |
709 |
0 |
78.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
237 |
0 |
294 |
0 |
80.6% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
803 |
0 |
1022 |
0 |
78.6% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.821 |
0 |
0.8311 |
None |
853 |
0 |
1022 |
0 |
83.5% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
106 |
0 |
120 |
0 |
88.3% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
58 |
0 |
77.6% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
661 |
0 |
784 |
0 |
84.3% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
853 |
0 |
1022 |
0 |
83.5% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
602 |
0 |
709 |
0 |
84.9% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
243 |
0 |
294 |
0 |
82.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
853 |
0 |
1022 |
0 |
83.5% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.5723 |
0 |
0.4576 |
None |
557 |
0 |
984 |
0 |
56.6% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9779 |
0 |
0.9434 |
None |
6424 |
0 |
6608 |
0 |
97.2% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.7901 |
0 |
0.7039 |
None |
279 |
0 |
335 |
0 |
83.3% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5574 |
0 |
0.5654 |
None |
3399 |
0 |
5825 |
0 |
58.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.7484 |
0 |
0.7575 |
None |
1656 |
0 |
2040 |
0 |
81.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.4962 |
0 |
0.5184 |
None |
30204 |
0 |
58197 |
0 |
51.9% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.394 |
0 |
0.5004 |
None |
18748 |
0 |
32126 |
0 |
58.4% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.3506 |
0 |
0.4075 |
None |
2077 |
0 |
6420 |
0 |
32.4% |
0 |
0 |
0 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9713 |
0 |
0 |
None |
46772 |
0 |
47406 |
0 |
98.7% |
0 |
N/A |
N/A |
YesI |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8722 |
0 |
0.8802 |
None |
42429 |
0 |
47406 |
0 |
89.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.6795 |
0 |
0.6909 |
None |
14161 |
0 |
16667 |
0 |
85.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.699 |
0 |
0.7116 |
None |
14476 |
0 |
16667 |
0 |
86.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.8298 |
0 |
0.834 |
None |
15899 |
0 |
16667 |
0 |
95.4% |
0 |
1 |
0.5 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.6477 |
0 |
0.6513 |
None |
545 |
0 |
704 |
0 |
77.4% |
0 |
1 |
1 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6941 |
0 |
0.7075 |
None |
1513 |
0 |
2036 |
0 |
74.3% |
0 |
1 |
1 |
YesS |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
1 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5063 |
0 |
0.5237 |
None |
8281 |
0 |
17006 |
0 |
48.7% |
0 |
0 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4537 |
0 |
0.4703 |
None |
16378 |
0 |
32868 |
0 |
49.8% |
0 |
1 |
1 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
32 |
0 |
46.9% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
1661 |
0 |
3078 |
0 |
54.0% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
594 |
0 |
1232 |
0 |
48.2% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
142 |
0 |
32.4% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
13073 |
0 |
25751 |
0 |
50.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
508 |
0 |
1031 |
0 |
49.3% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
481 |
0 |
1602 |
0 |
30.0% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
16378 |
0 |
32868 |
0 |
49.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
12920 |
0 |
25416 |
0 |
50.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
3305 |
0 |
6597 |
0 |
50.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
153 |
0 |
855 |
0 |
17.9% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
16378 |
0 |
32868 |
0 |
49.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.5929 |
0 |
0.5366 |
None |
1117 |
0 |
1859 |
0 |
60.1% |
0 |
1 |
1 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
181 |
0 |
230 |
0 |
78.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
79 |
0 |
35.4% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
844 |
0 |
1414 |
0 |
59.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
48 |
0 |
77 |
0 |
62.3% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
44 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1117 |
0 |
1859 |
0 |
60.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
845 |
0 |
1397 |
0 |
60.5% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
260 |
0 |
416 |
0 |
62.5% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
46 |
0 |
26.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1117 |
0 |
1859 |
0 |
60.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6059 |
0 |
0.6115 |
None |
2055 |
0 |
3351 |
0 |
61.3% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5771 |
0 |
0.5799 |
None |
13029 |
0 |
21075 |
0 |
61.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.7308 |
0 |
0.3665 |
None |
3304 |
0 |
4269 |
0 |
77.4% |
0 |
1 |
1 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.6888 |
0 |
0.6263 |
None |
23404 |
0 |
31600 |
0 |
74.1% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3037 |
0 |
0.3239 |
None |
701 |
0 |
2057 |
0 |
34.1% |
0 |
1 |
0 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
57 |
0 |
172 |
0 |
33.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
71 |
0 |
22.5% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
591 |
0 |
1676 |
0 |
35.3% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
53 |
0 |
37.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
77 |
0 |
18.2% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
701 |
0 |
2057 |
0 |
34.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
580 |
0 |
1624 |
0 |
35.7% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
113 |
0 |
379 |
0 |
29.8% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
54 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
701 |
0 |
2057 |
0 |
34.1% |
0 |
N/A |
None |
None |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
175 |
0 |
175 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9974 |
0 |
0.92 |
None |
2820 |
0 |
2833 |
0 |
99.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.7375 |
0 |
0.7558 |
None |
613 |
0 |
615 |
0 |
99.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.6431 |
0 |
0 |
None |
46 |
0 |
124.75 |
0 |
0.3687 |
0 |
1 |
N/A |
Yes |
PY5 |
Santa Clara Valley Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
1.8686 |
0 |
0 |
None |
25 |
0 |
17.498 |
0 |
1.4287 |
0 |
0 |
N/A |
Yes |
PY5 |
Seneca Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0 |
0 |
0.5004 |
None |
57 |
0 |
443 |
0 |
12.9% |
0 |
N/A |
N/A |
No |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
None |
2 |
0.2738 |
None |
39 |
0 |
131 |
0 |
29.8% |
0 |
1 |
0 |
Yes |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Seneca Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.752 |
0 |
0.7688 |
None |
64 |
0 |
65 |
0 |
98.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2337 |
0 |
0.2323 |
None |
74 |
0 |
254 |
0 |
29.1% |
0 |
0 |
0 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.5172 |
0 |
0.5417 |
None |
79 |
0 |
178 |
0 |
44.4% |
0 |
0 |
0 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.1077 |
0 |
0.7983 |
None |
85 |
0 |
101 |
0 |
84.2% |
0 |
1 |
0 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.0562 |
0 |
0.2671 |
None |
646 |
0 |
8585 |
0 |
7.5% |
0 |
N/A |
N/A |
No |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.0072 |
0 |
0.7542 |
None |
312 |
0 |
10048 |
0 |
3.1% |
0 |
N/A |
N/A |
NoS |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.0193 |
0 |
0.1094 |
None |
40 |
0 |
917 |
0 |
4.4% |
0 |
N/A |
N/A |
NoS |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9527 |
0 |
0 |
None |
9115 |
0 |
10208 |
0 |
89.3% |
0 |
N/A |
N/A |
NoS |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.9694 |
0 |
0.9918 |
None |
61 |
0 |
61 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9599 |
0 |
0.92 |
None |
252 |
0 |
279 |
0 |
90.3% |
0 |
0 |
0 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.5514 |
0 |
0.5883 |
None |
70 |
0 |
107 |
0 |
65.4% |
0 |
1 |
0 |
Yes |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.7533 |
0 |
0 |
None |
3 |
0 |
10.431 |
0 |
0.2876 |
0 |
N/A |
N/A |
No |
PY5 |
Sierra View District Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
1.7986 |
0 |
0 |
None |
1 |
0 |
2.136 |
0 |
0.4682 |
0 |
1 |
N/A |
Yes |
PY5 |
Sonoma Valley Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
0 |
None |
0 |
0 |
0.124 |
0 |
0 |
0 |
N/A |
N/A |
No |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
None |
2 |
N/A |
None |
14 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
No |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5348 |
0 |
0.5433 |
None |
26 |
0 |
51 |
0 |
51.0% |
0 |
0 |
0 |
Yes |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
37 |
0 |
51.4% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
51 |
0 |
51.0% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
37 |
0 |
54.1% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
51 |
0 |
51.0% |
0 |
N/A |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Southern Inyo Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
No Data Entered |
N/A |
3 |
N/A |
None |
None |
None |
None |
None |
None |
None |
N/A |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0 |
0 |
0.5004 |
None |
17 |
0 |
288 |
0 |
5.9% |
0 |
N/A |
N/A |
No |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.0992 |
0 |
0.1813 |
None |
30 |
0 |
42 |
0 |
71.4% |
0 |
1 |
0.5 |
YesS |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.5171 |
0 |
N/A |
None |
119 |
0 |
128 |
0 |
93.0% |
0 |
N/A |
N/A |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.5684 |
0 |
0.7542 |
None |
24 |
0 |
128 |
0 |
18.8% |
0 |
0 |
0 |
YesS |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Surprise Valley Community Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.2143 |
0 |
0.2159 |
None |
None |
1 |
51 |
0 |
None |
1 |
0 |
0 |
YesS |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.3036 |
0 |
0.3058 |
None |
12 |
0 |
51 |
0 |
23.5% |
0 |
0 |
0 |
YesS |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6373 |
0 |
0.6404 |
None |
88 |
0 |
146 |
0 |
60.3% |
0 |
N/A |
N/A |
No |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
None |
2 |
0.3406 |
None |
None |
1 |
50 |
0 |
None |
1 |
1 |
N/A |
YesS |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2182 |
0 |
0.3406 |
None |
19 |
0 |
93 |
0 |
20.4% |
0 |
1 |
N/A |
YesS |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
59 |
0 |
23.7% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
31 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
93 |
0 |
20.4% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
50 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
43 |
0 |
25.6% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
93 |
0 |
20.4% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.5686 |
0 |
0.5897 |
None |
59 |
0 |
100 |
0 |
59.0% |
0 |
1 |
0 |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6885 |
0 |
0.6959 |
None |
144 |
0 |
155 |
0 |
92.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.6202 |
0 |
0.622 |
None |
108 |
0 |
174 |
0 |
62.1% |
0 |
N/A |
N/A |
No |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.4195 |
0 |
0.5004 |
None |
778 |
0 |
1589 |
0 |
49.0% |
0 |
0 |
0 |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.6053 |
0 |
0.6128 |
None |
571 |
0 |
928 |
0 |
61.5% |
0 |
1 |
0 |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.2472 |
0 |
0.309 |
None |
18 |
0 |
87 |
0 |
20.7% |
0 |
N/A |
N/A |
No |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
70 |
0 |
21.4% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
87 |
0 |
20.7% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
45 |
0 |
28.9% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
40 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
87 |
0 |
20.7% |
0 |
N/A |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.7396 |
0 |
0.58 |
None |
0 |
0 |
2.555 |
0 |
0 |
0 |
1 |
N/A |
Yes |
PY5 |
Tahoe Forest Hospital District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 30 Days |
Reported |
None |
2 |
0.3894 |
None |
None |
1 |
478 |
0 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH5 |
Q-FUI |
â¶ 7 Days |
Reported |
None |
2 |
0.234 |
None |
None |
1 |
477 |
0 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Tri-City Medical Center |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0 |
0 |
N/A |
3 |
84 |
0 |
103 |
0 |
81.6% |
0 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
0 |
0 |
YesS |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
0 |
0 |
YesS |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.54 |
0 |
0.564 |
None |
0 |
0 |
0 |
0 |
0.0% |
0 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0 |
0 |
N/A |
None |
32 |
0 |
33 |
0 |
97.0% |
0 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2111 |
0 |
0.22 |
None |
46 |
0 |
250 |
0 |
18.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.4545 |
0 |
0.4853 |
None |
164 |
0 |
333 |
0 |
49.3% |
0 |
1 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
None |
2 |
0.1696 |
None |
None |
1 |
303 |
0 |
None |
1 |
N/A |
N/A |
No |
PY5 |
Tri-City Medical Center |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.8611 |
0 |
0.867 |
None |
23 |
0 |
None |
4 |
None |
4 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.8819 |
0 |
0.7182 |
None |
397 |
0 |
1206 |
0 |
32.9% |
0 |
N/A |
N/A |
No |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.0215 |
0 |
0.5004 |
None |
517 |
0 |
17691 |
0 |
2.9% |
0 |
N/A |
N/A |
No |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.0068 |
0 |
0.7542 |
None |
63 |
0 |
6877 |
0 |
0.9% |
0 |
N/A |
N/A |
NoS |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.0192 |
0 |
0.1093 |
None |
63 |
0 |
2272 |
0 |
2.8% |
0 |
N/A |
N/A |
NoS |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9489 |
0 |
0 |
None |
6545 |
0 |
6877 |
0 |
95.2% |
0 |
N/A |
N/A |
NoI |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
43 |
0 |
43 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.7312 |
0 |
0.7501 |
None |
169 |
0 |
169 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.9701 |
0 |
0.92 |
None |
None |
1 |
393 |
0 |
None |
1 |
0 |
0 |
Yes |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.8817 |
0 |
0 |
None |
19 |
0 |
25.897 |
0 |
0.7337 |
0 |
N/A |
N/A |
No |
PY5 |
Tri-City Medical Center |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
1.1952 |
0 |
0 |
None |
4 |
0 |
2.754 |
0 |
1.4524 |
0 |
N/A |
N/A |
No |
PY5 |
Trinity Hospital |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.1661 |
0 |
0.518 |
None |
222 |
0 |
603 |
0 |
36.8% |
0 |
N/A |
N/A |
No |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3013 |
0 |
0.3941 |
None |
262 |
0 |
730 |
0 |
35.9% |
0 |
0 |
0 |
Yes |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
29 |
0 |
78 |
0 |
37.2% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
232 |
0 |
638 |
0 |
36.4% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
262 |
0 |
730 |
0 |
35.9% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
260 |
0 |
713 |
0 |
36.5% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
262 |
0 |
730 |
0 |
35.9% |
0 |
N/A |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Trinity Hospital |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
None |
2 |
0.0848 |
None |
None |
1 |
124 |
0 |
None |
1 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
None |
2 |
0.0318 |
None |
None |
1 |
86 |
0 |
None |
1 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6279 |
0 |
0.6319 |
None |
141 |
0 |
209 |
0 |
67.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8143 |
0 |
0.8249 |
None |
765 |
0 |
914 |
0 |
83.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.3939 |
0 |
0.3886 |
None |
28 |
0 |
67 |
0 |
41.8% |
0 |
0 |
0 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.4 |
0 |
0.3941 |
None |
34 |
0 |
96 |
0 |
35.4% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3322 |
0 |
0.3406 |
None |
110 |
0 |
325 |
0 |
33.9% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
31 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
67 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
79 |
0 |
26.6% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
45 |
0 |
128 |
0 |
35.2% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
110 |
0 |
325 |
0 |
33.9% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
96 |
0 |
35.4% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
64 |
0 |
200 |
0 |
32.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
110 |
0 |
325 |
0 |
33.9% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.6784 |
0 |
0.6302 |
None |
213 |
0 |
325 |
0 |
65.5% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.5854 |
0 |
0.6022 |
None |
46 |
0 |
71 |
0 |
64.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9965 |
0 |
0.78 |
None |
252 |
0 |
257 |
0 |
98.1% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.7588 |
0 |
0 |
None |
18 |
0 |
17.5607 |
0 |
1.025 |
0 |
0 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Controlling High Blood Pressure (CBP) - -Black/African American |
Reported |
0.5769 |
0 |
0.586 |
None |
27 |
0 |
44 |
0 |
61.4% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Exclusive Breast Milk Feeding (PC-05) - -Black/African American |
Reported |
0.4267 |
0 |
0.4776 |
None |
19 |
0 |
37 |
0 |
51.4% |
0 |
1 |
0 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.5101 |
0 |
0.5353 |
None |
169 |
0 |
310 |
0 |
54.5% |
0 |
1 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7222 |
0 |
0.7337 |
None |
38 |
0 |
51 |
0 |
74.5% |
0 |
1 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
51 |
0 |
74.5% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
31 |
0 |
71.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
51 |
0 |
74.5% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.7593 |
0 |
0.7932 |
None |
46 |
0 |
51 |
0 |
90.2% |
0 |
1 |
1 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
51 |
0 |
90.2% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
31 |
0 |
90.3% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
51 |
0 |
90.2% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.549 |
0 |
0.4576 |
None |
25 |
0 |
50 |
0 |
50.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.9169 |
0 |
0.9172 |
None |
728 |
0 |
792 |
0 |
91.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.8444 |
0 |
0.8282 |
None |
59 |
0 |
67 |
0 |
88.1% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5372 |
0 |
0.5473 |
None |
172 |
0 |
309 |
0 |
55.7% |
0 |
1 |
0.25 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.4645 |
0 |
0.5079 |
None |
2603 |
0 |
4388 |
0 |
59.3% |
0 |
1 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.4267 |
0 |
0.476 |
None |
1571 |
0 |
2384 |
0 |
65.9% |
0 |
1 |
0 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8451 |
0 |
0.8558 |
None |
15566 |
0 |
17731 |
0 |
87.8% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9262 |
0 |
0 |
None |
16416 |
0 |
17768 |
0 |
92.4% |
0 |
N/A |
N/A |
YesI |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.3167 |
0 |
0.6643 |
None |
35 |
0 |
116 |
0 |
30.2% |
0 |
0 |
0 |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
None |
2 |
0.4499 |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.2723 |
0 |
0.3941 |
None |
497 |
0 |
1863 |
0 |
26.7% |
0 |
0 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
85 |
0 |
36.5% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
85 |
0 |
198 |
0 |
42.9% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
67 |
0 |
230 |
0 |
29.1% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
92 |
0 |
40.2% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
273 |
0 |
1245 |
0 |
21.9% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
497 |
0 |
1863 |
0 |
26.7% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
159 |
0 |
396 |
0 |
40.2% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
218 |
0 |
598 |
0 |
36.5% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
120 |
0 |
869 |
0 |
13.8% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
497 |
0 |
1863 |
0 |
26.7% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.195 |
0 |
0.3187 |
None |
14 |
0 |
55 |
0 |
25.5% |
0 |
0 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
55 |
0 |
25.5% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
55 |
0 |
25.5% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6111 |
0 |
0.6161 |
None |
38 |
0 |
80 |
0 |
47.5% |
0 |
0 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.4433 |
0 |
0.4594 |
None |
1641 |
0 |
3000 |
0 |
54.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.079 |
0 |
0.1765 |
None |
39 |
0 |
152 |
0 |
25.7% |
0 |
1 |
1 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.7977 |
0 |
0.6263 |
None |
1194 |
0 |
1464 |
0 |
81.6% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.2308 |
0 |
0.309 |
None |
21 |
0 |
105 |
0 |
20.0% |
0 |
0 |
0 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
69 |
0 |
24.6% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
105 |
0 |
20.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
35 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
47 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
105 |
0 |
20.0% |
0 |
N/A |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.9307 |
0 |
0.9918 |
None |
128 |
0 |
128 |
0 |
100.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9772 |
0 |
0.92 |
None |
4273 |
0 |
4398 |
0 |
97.2% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Davis Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Davis Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.0548 |
0 |
0.0848 |
None |
16 |
0 |
269 |
0 |
6.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.1392 |
0 |
0.1405 |
None |
45 |
0 |
298 |
0 |
15.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.1701 |
0 |
0.1792 |
None |
55 |
0 |
298 |
0 |
18.5% |
0 |
1 |
0.25 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.299 |
0 |
0.3605 |
None |
107 |
0 |
298 |
0 |
35.9% |
0 |
0 |
0 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
YesI |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesI |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesI |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.1348 |
0 |
0.1539 |
None |
33 |
0 |
119 |
0 |
27.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
None |
2 |
0.0938 |
None |
17 |
0 |
119 |
0 |
14.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.5797 |
0 |
0.5885 |
None |
918 |
0 |
1423 |
0 |
64.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8271 |
0 |
0.8364 |
None |
960 |
0 |
1163 |
0 |
82.6% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8467 |
0 |
0.854 |
None |
1832 |
0 |
2176 |
0 |
84.2% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8367 |
0 |
0.8408 |
None |
554 |
0 |
665 |
0 |
83.3% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7243 |
0 |
0.7357 |
None |
1451 |
0 |
2019 |
0 |
71.9% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
0.3406 |
None |
12 |
0 |
42 |
0 |
28.6% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3216 |
0 |
0.3406 |
None |
420 |
0 |
1275 |
0 |
32.9% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.32 |
0 |
0.3406 |
None |
564 |
0 |
1686 |
0 |
33.5% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
126 |
0 |
25.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
40 |
0 |
27.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
399 |
0 |
1185 |
0 |
33.7% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
94 |
0 |
37.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
79 |
0 |
222 |
0 |
35.6% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
564 |
0 |
1686 |
0 |
33.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
420 |
0 |
1275 |
0 |
32.9% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
141 |
0 |
404 |
0 |
34.9% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
564 |
0 |
1686 |
0 |
33.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.3129 |
0 |
0.4501 |
None |
403 |
0 |
1688 |
0 |
23.9% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.6056 |
0 |
0.4676 |
None |
831 |
0 |
1577 |
0 |
52.7% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.7382 |
0 |
0.773 |
None |
233 |
0 |
344 |
0 |
67.7% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.7052 |
0 |
0.71 |
None |
143 |
0 |
172 |
0 |
83.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.999 |
0 |
0.78 |
None |
1192 |
0 |
1206 |
0 |
98.8% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.8281 |
0 |
0 |
None |
40 |
0 |
52.74 |
0 |
0.7584 |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1756 |
0 |
0.22 |
None |
47 |
0 |
285 |
0 |
16.5% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6059 |
0 |
0.6215 |
None |
126 |
0 |
173 |
0 |
72.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8225 |
0 |
0.824 |
None |
388 |
0 |
472 |
0 |
82.2% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
30 |
0 |
76.7% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
269 |
0 |
326 |
0 |
82.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
64 |
0 |
80 |
0 |
80.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
388 |
0 |
472 |
0 |
82.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
278 |
0 |
338 |
0 |
82.3% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
105 |
0 |
129 |
0 |
81.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
388 |
0 |
472 |
0 |
82.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.7528 |
0 |
0.7932 |
None |
368 |
0 |
472 |
0 |
78.0% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
30 |
0 |
86.7% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
254 |
0 |
326 |
0 |
77.9% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
22 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
55 |
0 |
80 |
0 |
68.8% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
368 |
0 |
472 |
0 |
78.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
261 |
0 |
338 |
0 |
77.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
106 |
0 |
129 |
0 |
82.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
368 |
0 |
472 |
0 |
78.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Reported |
0.4863 |
0 |
0.4576 |
None |
199 |
0 |
483 |
0 |
41.2% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9809 |
0 |
0.9434 |
None |
1092 |
0 |
1117 |
0 |
97.8% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.9337 |
0 |
0.8282 |
None |
494 |
0 |
522 |
0 |
94.6% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5255 |
0 |
0.5367 |
None |
723 |
0 |
1287 |
0 |
56.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.4602 |
0 |
0.6131 |
None |
210 |
0 |
393 |
0 |
53.4% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.4411 |
0 |
0.4955 |
None |
7198 |
0 |
17318 |
0 |
41.6% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.5575 |
0 |
0.5916 |
None |
8997 |
0 |
15939 |
0 |
56.5% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.3246 |
0 |
0.3841 |
None |
620 |
0 |
1748 |
0 |
35.5% |
0 |
0.5 |
0 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9157 |
0 |
0.9194 |
None |
22906 |
0 |
24868 |
0 |
92.1% |
0 |
1 |
0 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.967 |
0 |
0 |
None |
24298 |
0 |
25132 |
0 |
96.7% |
0 |
N/A |
N/A |
YesI |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.75 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.8142 |
0 |
0.7932 |
None |
2935 |
0 |
3669 |
0 |
80.0% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.816 |
0 |
0.8169 |
None |
2940 |
0 |
3669 |
0 |
80.1% |
0 |
0 |
0 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.9838 |
0 |
0.8718 |
None |
3641 |
0 |
3669 |
0 |
99.2% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.6339 |
0 |
0.6388 |
None |
160 |
0 |
199 |
0 |
80.4% |
0 |
1 |
1 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6485 |
0 |
0.6665 |
None |
306 |
0 |
417 |
0 |
73.4% |
0 |
1 |
1 |
YesS |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
1 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5345 |
0 |
0.549 |
None |
3829 |
0 |
6930 |
0 |
55.3% |
0 |
1 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4494 |
0 |
0.4664 |
None |
3128 |
0 |
6921 |
0 |
45.2% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
159 |
0 |
298 |
0 |
53.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
73 |
0 |
144 |
0 |
50.7% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
2357 |
0 |
4771 |
0 |
49.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
40 |
0 |
108 |
0 |
37.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
483 |
0 |
1564 |
0 |
30.9% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
3128 |
0 |
6921 |
0 |
45.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2527 |
0 |
5088 |
0 |
49.7% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
582 |
0 |
1216 |
0 |
47.9% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
617 |
0 |
3.1% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
3128 |
0 |
6921 |
0 |
45.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.5505 |
0 |
0.5366 |
None |
201 |
0 |
391 |
0 |
51.4% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
129 |
0 |
246 |
0 |
52.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
46 |
0 |
99 |
0 |
46.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
201 |
0 |
391 |
0 |
51.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
149 |
0 |
283 |
0 |
52.7% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
88 |
0 |
56.8% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
201 |
0 |
391 |
0 |
51.4% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6414 |
0 |
0.6434 |
None |
543 |
0 |
825 |
0 |
65.8% |
0 |
1 |
1 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.5214 |
0 |
0.5297 |
None |
3129 |
0 |
6693 |
0 |
46.8% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.4443 |
0 |
0.3665 |
None |
585 |
0 |
981 |
0 |
59.6% |
0 |
1 |
1 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.5896 |
0 |
0.5933 |
None |
6732 |
0 |
9457 |
0 |
71.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3902 |
0 |
0.4018 |
None |
92 |
0 |
292 |
0 |
31.5% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
73 |
0 |
205 |
0 |
35.6% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
68 |
0 |
25.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
92 |
0 |
292 |
0 |
31.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
79 |
0 |
218 |
0 |
36.2% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
50 |
0 |
26.0% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
92 |
0 |
292 |
0 |
31.5% |
0 |
N/A |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.936 |
0 |
0.9918 |
None |
215 |
0 |
227 |
0 |
94.7% |
0 |
0 |
0 |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.972 |
0 |
0.92 |
None |
4066 |
0 |
4122 |
0 |
98.6% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Irvine Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.8666 |
0 |
0 |
None |
22 |
0 |
36.524 |
0 |
0.6023 |
0 |
1 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.7089 |
0 |
0.6679 |
None |
55 |
0 |
78 |
0 |
70.5% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8045 |
0 |
0.816 |
None |
1400 |
0 |
1717 |
0 |
81.5% |
0 |
0.75 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.5909 |
0 |
0.6969 |
None |
587 |
0 |
736 |
0 |
79.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2941 |
None |
0.3406 |
None |
15 |
0 |
46 |
0 |
32.6% |
0 |
1 |
N/A |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
46 |
0 |
32.6% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
46 |
0 |
32.6% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5513 |
0 |
0.4501 |
None |
19 |
0 |
46 |
0 |
41.3% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.4783 |
0 |
0.4676 |
None |
23 |
0 |
43 |
0 |
53.5% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
1 |
0 |
0.78 |
None |
42 |
0 |
42 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
0.336 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Colorectal Cancer Screening - -Native Hawaiian/Pacific Islander |
Reported |
None |
2 |
0.3059 |
None |
14 |
0 |
38 |
0 |
36.8% |
0 |
1 |
0 |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.2713 |
0 |
0.2481 |
None |
33 |
0 |
168 |
0 |
19.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.491 |
0 |
0.5181 |
None |
167 |
0 |
343 |
0 |
48.7% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.9787 |
0 |
0.9434 |
None |
397 |
0 |
411 |
0 |
96.6% |
0 |
1 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.9185 |
0 |
0.9186 |
None |
321 |
0 |
377 |
0 |
85.2% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5306 |
0 |
0.5413 |
None |
48 |
0 |
93 |
0 |
51.6% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.5026 |
0 |
0.6131 |
None |
94 |
0 |
181 |
0 |
51.9% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.1924 |
0 |
0.5004 |
None |
5873 |
0 |
30834 |
0 |
19.1% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.1704 |
0 |
0.6107 |
None |
1671 |
0 |
2806 |
0 |
59.6% |
0 |
0 |
0 |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.1733 |
0 |
0.5579 |
None |
1384 |
0 |
2806 |
0 |
49.3% |
0 |
0 |
0 |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.318 |
0 |
0.6919 |
None |
2601 |
0 |
2806 |
0 |
92.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.3333 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.5385 |
0 |
0.553 |
None |
27 |
0 |
41 |
0 |
65.9% |
0 |
1 |
1 |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.5944 |
0 |
0.6643 |
None |
150 |
0 |
209 |
0 |
71.8% |
0 |
1 |
1 |
YesS |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
1 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5513 |
0 |
0.5642 |
None |
121 |
0 |
248 |
0 |
48.8% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5257 |
0 |
0.5351 |
None |
2260 |
0 |
4339 |
0 |
52.1% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
33 |
0 |
36.4% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
106 |
0 |
186 |
0 |
57.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
185 |
0 |
355 |
0 |
52.1% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
712 |
0 |
1445 |
0 |
49.3% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
154 |
0 |
259 |
0 |
59.5% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1085 |
0 |
2051 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
2260 |
0 |
4339 |
0 |
52.1% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
1295 |
0 |
2343 |
0 |
55.3% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
797 |
0 |
1576 |
0 |
50.6% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
168 |
0 |
420 |
0 |
40.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
2260 |
0 |
4339 |
0 |
52.1% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.3968 |
0 |
0.4108 |
None |
84 |
0 |
177 |
0 |
47.5% |
0 |
1 |
1 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
53 |
0 |
112 |
0 |
47.3% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
84 |
0 |
177 |
0 |
47.5% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
93 |
0 |
53.8% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
29 |
0 |
74 |
0 |
39.2% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
84 |
0 |
177 |
0 |
47.5% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5513 |
0 |
0.5623 |
None |
89 |
0 |
175 |
0 |
50.9% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.336 |
0 |
0.3629 |
None |
4977 |
0 |
14750 |
0 |
33.7% |
0 |
0 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.1679 |
0 |
0.1878 |
None |
87 |
0 |
455 |
0 |
19.1% |
0 |
1 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.4234 |
0 |
0.4437 |
None |
499 |
0 |
1144 |
0 |
43.6% |
0 |
0.5 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3562 |
0 |
0.3712 |
None |
96 |
0 |
257 |
0 |
37.4% |
0 |
1 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
39 |
0 |
121 |
0 |
32.2% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
41 |
0 |
93 |
0 |
44.1% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
96 |
0 |
257 |
0 |
37.4% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
143 |
0 |
43.4% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
95 |
0 |
29.5% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
96 |
0 |
257 |
0 |
37.4% |
0 |
N/A |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.6533 |
0 |
0.68 |
None |
2890 |
0 |
3467 |
0 |
83.4% |
0 |
1 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.4999 |
0 |
0.5419 |
None |
1660 |
0 |
2780 |
0 |
59.7% |
0 |
1 |
0 |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.8976 |
0 |
0 |
None |
62 |
0 |
108.75 |
0 |
0.5701 |
0 |
0 |
N/A |
Yes |
PY5 |
UC Los Angeles Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.1927 |
0 |
0.1415 |
None |
11 |
0 |
99 |
0 |
11.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
YesI |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
0 |
0 |
N/A |
None |
0 |
0 |
None |
1 |
None |
1 |
N/A |
N/A |
YesI |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0 |
0 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
YesI |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
None |
2 |
N/A |
None |
11 |
0 |
87 |
0 |
12.6% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
None |
2 |
N/A |
None |
18 |
0 |
87 |
0 |
20.7% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
None |
2 |
N/A |
None |
52 |
0 |
87 |
0 |
59.8% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
None |
2 |
0.0397 |
None |
None |
1 |
82 |
0 |
None |
1 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6585 |
0 |
0.6594 |
None |
187 |
0 |
277 |
0 |
67.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.7972 |
0 |
0.8095 |
None |
1028 |
0 |
1265 |
0 |
81.3% |
0 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.8422 |
0 |
0.85 |
None |
2504 |
0 |
2996 |
0 |
83.6% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.766 |
0 |
0.7772 |
None |
893 |
0 |
1130 |
0 |
79.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.619 |
0 |
0.6667 |
None |
287 |
0 |
385 |
0 |
74.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
None |
2 |
0.3406 |
None |
None |
1 |
39 |
0 |
None |
1 |
1 |
N/A |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2299 |
0 |
0.3406 |
None |
38 |
0 |
188 |
0 |
20.2% |
0 |
1 |
N/A |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
80 |
0 |
21.3% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
55 |
0 |
23.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
188 |
0 |
20.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
38 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
27 |
0 |
146 |
0 |
18.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
38 |
0 |
188 |
0 |
20.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5862 |
0 |
0.5906 |
None |
113 |
0 |
188 |
0 |
60.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.5754 |
0 |
0.4676 |
None |
112 |
0 |
193 |
0 |
58.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.8039 |
0 |
0.8072 |
None |
114 |
0 |
129 |
0 |
88.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.8478 |
0 |
0.7532 |
None |
28 |
0 |
33 |
0 |
84.9% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
0 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
0 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
1 |
0 |
0.78 |
None |
128 |
0 |
128 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.698 |
0 |
0 |
None |
8 |
0 |
9.079 |
0 |
0.8812 |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.4174 |
0 |
0.4799 |
None |
5432 |
0 |
10574 |
0 |
51.4% |
0 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Child and Adolescent Well Care Visits - -Black/African American |
Reported |
0.3611 |
0 |
0.3941 |
None |
42 |
0 |
95 |
0 |
44.2% |
0 |
1 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ HIV Viral Suppression (HVL-AD) - -Hispanic/Latino |
Reported |
0.7692 |
0 |
0.776 |
None |
30 |
0 |
35 |
0 |
85.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.7205 |
0 |
0.7247 |
None |
892 |
0 |
1193 |
0 |
74.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5931 |
0 |
0.5976 |
None |
228 |
0 |
329 |
0 |
69.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.5732 |
0 |
0.6131 |
None |
125 |
0 |
170 |
0 |
73.5% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.4581 |
0 |
0.5052 |
None |
1777 |
0 |
4406 |
0 |
40.3% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.6633 |
0 |
0.6869 |
None |
1787 |
0 |
2492 |
0 |
71.7% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.4345 |
0 |
0.483 |
None |
1289 |
0 |
2325 |
0 |
55.4% |
0 |
1 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.8688 |
0 |
0.8772 |
None |
22302 |
0 |
24439 |
0 |
91.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9332 |
0 |
0 |
None |
23743 |
0 |
24844 |
0 |
95.6% |
0 |
N/A |
N/A |
YesI |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.6006 |
0 |
0.6199 |
None |
622 |
0 |
947 |
0 |
65.7% |
0 |
1 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.6149 |
0 |
0.6359 |
None |
638 |
0 |
947 |
0 |
67.4% |
0 |
1 |
0 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.6513 |
0 |
0.6919 |
None |
748 |
0 |
947 |
0 |
79.0% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.4151 |
0 |
0.4499 |
None |
25 |
0 |
34 |
0 |
73.5% |
0 |
1 |
1 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6481 |
0 |
0.6661 |
None |
128 |
0 |
181 |
0 |
70.7% |
0 |
1 |
1 |
YesS |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
1 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.5964 |
0 |
0.6048 |
None |
493 |
0 |
791 |
0 |
62.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.4667 |
0 |
0.482 |
None |
764 |
0 |
1539 |
0 |
49.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
54 |
0 |
99 |
0 |
54.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
42 |
0 |
95 |
0 |
44.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
248 |
0 |
462 |
0 |
53.7% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
37 |
0 |
54.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
393 |
0 |
835 |
0 |
47.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
764 |
0 |
1539 |
0 |
49.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
245 |
0 |
463 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
349 |
0 |
674 |
0 |
51.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
170 |
0 |
402 |
0 |
42.3% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
764 |
0 |
1539 |
0 |
49.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.1585 |
0 |
0.3187 |
None |
70 |
0 |
169 |
0 |
41.4% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
30 |
0 |
66 |
0 |
45.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
65 |
0 |
29.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
70 |
0 |
169 |
0 |
41.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
24 |
0 |
59 |
0 |
40.7% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
44 |
0 |
92 |
0 |
47.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
70 |
0 |
169 |
0 |
41.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5588 |
0 |
0.5691 |
None |
25 |
0 |
55 |
0 |
45.5% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.7526 |
0 |
0.6046 |
None |
1587 |
0 |
2096 |
0 |
75.7% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.4316 |
0 |
0.3665 |
None |
251 |
0 |
384 |
0 |
65.4% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.553 |
0 |
0.5603 |
None |
696 |
0 |
1092 |
0 |
63.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
38 |
0 |
34.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
60 |
0 |
35.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
60 |
0 |
35.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
None |
2 |
0.309 |
None |
21 |
0 |
60 |
0 |
35.0% |
0 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9741 |
0 |
0.92 |
None |
5628 |
0 |
5765 |
0 |
97.6% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.596 |
0 |
0.6284 |
None |
2346 |
0 |
3035 |
0 |
77.3% |
0 |
1 |
0 |
Yes |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Diego Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.1474 |
0 |
0.1411 |
None |
45 |
0 |
367 |
0 |
12.3% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adults) |
Reported |
0.0988 |
0 |
0.1041 |
None |
37 |
0 |
345 |
0 |
10.7% |
0 |
1 |
0.25 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adults) |
Reported |
0.1698 |
0 |
0.1789 |
None |
59 |
0 |
345 |
0 |
17.1% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adults) |
Reported |
0.5247 |
0 |
0.5391 |
None |
195 |
0 |
345 |
0 |
56.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Remission (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
YesI |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Depression Response (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
0 |
0 |
None |
4 |
None |
4 |
N/A |
N/A |
YesI |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
â¶ Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
YesI |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
None |
2 |
0.2057 |
None |
14 |
0 |
42 |
0 |
33.3% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
None |
2 |
0.0749 |
None |
None |
1 |
42 |
0 |
None |
1 |
1 |
0.5 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.6171 |
0 |
0.6222 |
None |
919 |
0 |
1398 |
0 |
65.7% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8214 |
0 |
0.8313 |
None |
854 |
0 |
1019 |
0 |
83.8% |
0 |
1 |
0.25 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8549 |
0 |
0.8572 |
None |
578 |
0 |
661 |
0 |
87.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.7338 |
0 |
0.7442 |
None |
1210 |
0 |
1605 |
0 |
75.4% |
0 |
1 |
0.25 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.2948 |
0 |
0.3406 |
None |
59 |
0 |
221 |
0 |
26.7% |
0 |
1 |
N/A |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.2832 |
0 |
0.3406 |
None |
28 |
0 |
131 |
0 |
21.4% |
0 |
1 |
N/A |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2475 |
0 |
0.3406 |
None |
210 |
0 |
933 |
0 |
22.5% |
0 |
1 |
N/A |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
52 |
0 |
311 |
0 |
16.7% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
55 |
0 |
201 |
0 |
27.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
42 |
0 |
149 |
0 |
28.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
49 |
0 |
22.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
43 |
0 |
201 |
0 |
21.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
210 |
0 |
933 |
0 |
22.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
28 |
0 |
131 |
0 |
21.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
172 |
0 |
786 |
0 |
21.9% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
210 |
0 |
933 |
0 |
22.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5609 |
0 |
0.5678 |
None |
551 |
0 |
935 |
0 |
58.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.6039 |
0 |
0.4676 |
None |
617 |
0 |
950 |
0 |
65.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.9022 |
0 |
0.837 |
None |
473 |
0 |
544 |
0 |
87.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.6044 |
0 |
0.6193 |
None |
113 |
0 |
198 |
0 |
57.1% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Systemic Corticosteroid |
Reported |
0.5814 |
0 |
0.636 |
None |
28 |
0 |
41 |
0 |
68.3% |
0 |
1 |
0 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
â¶ Bronchodilator |
Reported |
0.907 |
0 |
0.9057 |
None |
39 |
0 |
41 |
0 |
95.1% |
0 |
1 |
N/A |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
1 |
0 |
0.78 |
None |
714 |
0 |
729 |
0 |
97.9% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
1.0055 |
0 |
0 |
None |
29 |
0 |
36.8732 |
0 |
0.7865 |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.7868 |
0 |
0.8001 |
None |
4522 |
0 |
12126 |
0 |
37.3% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Controlling High Blood Pressure (CBP) - -Black/African American |
Reported |
0.5481 |
0 |
0.5601 |
None |
225 |
0 |
345 |
0 |
65.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.8069 |
0 |
0.8099 |
None |
121 |
0 |
143 |
0 |
84.6% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
32 |
0 |
43 |
0 |
74.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
42 |
0 |
88.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
121 |
0 |
143 |
0 |
84.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
92 |
0 |
112 |
0 |
82.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
121 |
0 |
143 |
0 |
84.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.5586 |
0 |
0.7932 |
None |
123 |
0 |
143 |
0 |
86.0% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
43 |
0 |
86.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
42 |
0 |
73.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
123 |
0 |
143 |
0 |
86.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
97 |
0 |
112 |
0 |
86.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
123 |
0 |
143 |
0 |
86.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.981 |
0 |
0.9434 |
None |
590 |
0 |
598 |
0 |
98.7% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.8209 |
0 |
0.8216 |
None |
385 |
0 |
451 |
0 |
85.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5541 |
0 |
0.5625 |
None |
900 |
0 |
1380 |
0 |
65.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.4574 |
0 |
0.6131 |
None |
143 |
0 |
242 |
0 |
59.1% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.6382 |
0 |
0.6462 |
None |
21876 |
0 |
34737 |
0 |
63.0% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.5722 |
0 |
0.6049 |
None |
3938 |
0 |
6580 |
0 |
59.9% |
0 |
0.75 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.4448 |
0 |
0.4923 |
None |
899 |
0 |
2173 |
0 |
41.4% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9215 |
0 |
0.9246 |
None |
24129 |
0 |
26872 |
0 |
89.8% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9758 |
0 |
0 |
None |
25403 |
0 |
26872 |
0 |
94.5% |
0 |
N/A |
N/A |
YesI |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.6062 |
0 |
0.6249 |
None |
2441 |
0 |
3142 |
0 |
77.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.6205 |
0 |
0.6409 |
None |
2447 |
0 |
3142 |
0 |
77.9% |
0 |
1 |
0.5 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.906 |
0 |
0.8718 |
None |
2856 |
0 |
3142 |
0 |
90.9% |
0 |
1 |
N/A |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.6381 |
0 |
0.6426 |
None |
53 |
0 |
75 |
0 |
70.7% |
0 |
1 |
1 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.691 |
0 |
0.7047 |
None |
155 |
0 |
242 |
0 |
64.1% |
0 |
0 |
0 |
YesS |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.6453 |
0 |
0.6488 |
None |
2690 |
0 |
4025 |
0 |
66.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.6323 |
0 |
0.6197 |
None |
3178 |
0 |
5221 |
0 |
60.9% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
631 |
0 |
915 |
0 |
69.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
624 |
0 |
1156 |
0 |
54.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
34 |
0 |
76 |
0 |
44.7% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
437 |
0 |
716 |
0 |
61.0% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
276 |
0 |
472 |
0 |
58.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
1164 |
0 |
1863 |
0 |
62.5% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
3178 |
0 |
5221 |
0 |
60.9% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
978 |
0 |
1535 |
0 |
63.7% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2125 |
0 |
3508 |
0 |
60.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
75 |
0 |
178 |
0 |
42.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
3178 |
0 |
5221 |
0 |
60.9% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.5078 |
0 |
0.5107 |
None |
99 |
0 |
241 |
0 |
41.1% |
0 |
0 |
0 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
54 |
0 |
64.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
51 |
0 |
21.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
30 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
81 |
0 |
43.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
99 |
0 |
241 |
0 |
41.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
30 |
0 |
67 |
0 |
44.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
64 |
0 |
165 |
0 |
38.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
99 |
0 |
241 |
0 |
41.1% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.515 |
0 |
0.5297 |
None |
229 |
0 |
401 |
0 |
57.1% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.6664 |
0 |
0.6046 |
None |
2857 |
0 |
4322 |
0 |
66.1% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.5502 |
0 |
0.3665 |
None |
335 |
0 |
509 |
0 |
65.8% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.7203 |
0 |
0.6263 |
None |
4680 |
0 |
6402 |
0 |
73.1% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3534 |
0 |
0.3687 |
None |
115 |
0 |
282 |
0 |
40.8% |
0 |
1 |
1 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
58 |
0 |
60.3% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
75 |
0 |
22.7% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
32 |
0 |
40.6% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
41 |
0 |
98 |
0 |
41.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
115 |
0 |
282 |
0 |
40.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
31 |
0 |
64 |
0 |
48.4% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
84 |
0 |
204 |
0 |
41.2% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
115 |
0 |
282 |
0 |
40.8% |
0 |
N/A |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
1 |
0 |
1 |
None |
103 |
0 |
103 |
0 |
100.0% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9878 |
0 |
0.92 |
None |
4448 |
0 |
4554 |
0 |
97.7% |
0 |
1 |
N/A |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.9143 |
0 |
0.9149 |
None |
2544 |
0 |
2747 |
0 |
92.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
UC San Francisco Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.6504 |
0 |
0 |
None |
35 |
0 |
54.504 |
0 |
0.6422 |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.1225 |
0 |
0.1187 |
None |
109 |
0 |
1033 |
0 |
10.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 7 Days |
Reported |
0.1047 |
0 |
0.1172 |
None |
42 |
0 |
254 |
0 |
16.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH3 |
Q-FUA |
â¶ 30 Days |
Reported |
0.2016 |
0 |
0.214 |
None |
78 |
0 |
254 |
0 |
30.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.0345 |
0 |
0.0337 |
None |
20 |
0 |
845 |
0 |
2.4% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.5447 |
0 |
0.557 |
None |
2414 |
0 |
4083 |
0 |
59.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.8259 |
0 |
0.8353 |
None |
381 |
0 |
437 |
0 |
87.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.9272 |
0 |
0.9199 |
None |
824 |
0 |
887 |
0 |
92.9% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.8365 |
0 |
0.8406 |
None |
232 |
0 |
267 |
0 |
86.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
0.381 |
0 |
0.377 |
None |
27 |
0 |
70 |
0 |
38.6% |
0 |
0 |
0 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
0.3669 |
0 |
0.3643 |
None |
709 |
0 |
2041 |
0 |
34.7% |
0 |
1 |
0.5 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.3568 |
0 |
0.3552 |
None |
1102 |
0 |
3195 |
0 |
34.5% |
0 |
1 |
0.5 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.6667 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
58 |
0 |
29.3% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
50 |
0 |
218 |
0 |
22.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
65 |
0 |
40.0% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
970 |
0 |
2748 |
0 |
35.3% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
34 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
30 |
0 |
64 |
0 |
46.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
1102 |
0 |
3195 |
0 |
34.5% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
709 |
0 |
2041 |
0 |
34.7% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
356 |
0 |
1084 |
0 |
32.8% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
70 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
1102 |
0 |
3195 |
0 |
34.5% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.4872 |
0 |
0.5015 |
None |
1949 |
0 |
3195 |
0 |
61.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.5248 |
0 |
0.4676 |
None |
1824 |
0 |
3270 |
0 |
55.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.5778 |
0 |
0.773 |
None |
199 |
0 |
252 |
0 |
79.0% |
0 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Reported |
0.9503 |
0 |
0.78 |
None |
1616 |
0 |
1705 |
0 |
94.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
â¶ Chlamydia Screening in Women (CHL) - -American Indian/Alaskan Native |
Reported |
0.43 |
0 |
0.4829 |
None |
63 |
0 |
125 |
0 |
50.4% |
0 |
1 |
0 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
â¶ Preventive Care and Screening: Influenza Immunization - -Black/African American |
Reported |
0.4513 |
0 |
0.478 |
None |
252 |
0 |
426 |
0 |
59.2% |
0 |
1 |
0.5 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.1859 |
0 |
0.22 |
None |
58 |
0 |
345 |
0 |
16.8% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6747 |
0 |
0.6834 |
None |
918 |
0 |
1095 |
0 |
83.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.7882 |
0 |
0.7931 |
None |
662 |
0 |
804 |
0 |
82.3% |
0 |
1 |
1 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
589 |
0 |
712 |
0 |
82.7% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
31 |
0 |
83.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
11 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
662 |
0 |
804 |
0 |
82.3% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
524 |
0 |
620 |
0 |
84.5% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
126 |
0 |
166 |
0 |
75.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH4 |
Q-PPC-PST |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
662 |
0 |
804 |
0 |
82.3% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.8472 |
0 |
0.8547 |
None |
711 |
0 |
804 |
0 |
88.4% |
0 |
1 |
1 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
17 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
15 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
633 |
0 |
712 |
0 |
88.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
25 |
0 |
31 |
0 |
80.7% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
711 |
0 |
804 |
0 |
88.4% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
553 |
0 |
620 |
0 |
89.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
144 |
0 |
166 |
0 |
86.8% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH5 |
Q-PPC-PRE |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
711 |
0 |
804 |
0 |
88.4% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.9506 |
0 |
0.7039 |
None |
175 |
0 |
205 |
0 |
85.4% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.6813 |
0 |
0.7983 |
None |
148 |
0 |
173 |
0 |
85.6% |
0 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.8856 |
0 |
0.8282 |
None |
522 |
0 |
582 |
0 |
89.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.5338 |
0 |
0.5442 |
None |
2269 |
0 |
3925 |
0 |
57.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.4855 |
0 |
0.6131 |
None |
899 |
0 |
1560 |
0 |
57.6% |
0 |
0 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.6369 |
0 |
0.6661 |
None |
21594 |
0 |
29627 |
0 |
72.9% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.5935 |
0 |
0.606 |
None |
18379 |
0 |
25969 |
0 |
70.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.6236 |
0 |
0.6511 |
None |
19736 |
0 |
31612 |
0 |
62.4% |
0 |
0 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.5168 |
0 |
0.5571 |
None |
1373 |
0 |
2432 |
0 |
56.5% |
0 |
1 |
0 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9476 |
0 |
0.9481 |
None |
32631 |
0 |
33948 |
0 |
96.1% |
0 |
1 |
0.5 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9933 |
0 |
0 |
None |
33692 |
0 |
33950 |
0 |
99.2% |
0 |
N/A |
N/A |
YesI |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6655 |
0 |
0.6818 |
None |
1126 |
0 |
1631 |
0 |
69.0% |
0 |
1 |
0 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
0.7246 |
0 |
0.6833 |
None |
300 |
0 |
378 |
0 |
79.4% |
0 |
1 |
1 |
YesS |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.529 |
0 |
0.5441 |
None |
9233 |
0 |
16607 |
0 |
55.6% |
0 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.3918 |
0 |
0.4146 |
None |
15168 |
0 |
36006 |
0 |
42.1% |
0 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
511 |
0 |
1138 |
0 |
44.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
294 |
0 |
767 |
0 |
38.3% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
183 |
0 |
517 |
0 |
35.4% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
14 |
0 |
46 |
0 |
30.4% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
13454 |
0 |
30608 |
0 |
44.0% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
494 |
0 |
795 |
0 |
62.1% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
218 |
0 |
2135 |
0 |
10.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
15168 |
0 |
36006 |
0 |
42.1% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
12147 |
0 |
26293 |
0 |
46.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
2512 |
0 |
6576 |
0 |
38.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
509 |
0 |
3137 |
0 |
16.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
15168 |
0 |
36006 |
0 |
42.1% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.3776 |
0 |
0.3935 |
None |
590 |
0 |
1468 |
0 |
40.2% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
53 |
0 |
77 |
0 |
68.8% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
457 |
0 |
1185 |
0 |
38.6% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
62 |
0 |
106 |
0 |
58.5% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
66 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
590 |
0 |
1468 |
0 |
40.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
510 |
0 |
1149 |
0 |
44.4% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
74 |
0 |
262 |
0 |
28.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
57 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
590 |
0 |
1468 |
0 |
40.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.5127 |
0 |
0.5276 |
None |
1603 |
0 |
2846 |
0 |
56.3% |
0 |
1 |
1 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.4625 |
0 |
0.4767 |
None |
6798 |
0 |
13716 |
0 |
49.6% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.4148 |
0 |
0.3665 |
None |
1584 |
0 |
3275 |
0 |
48.4% |
0 |
1 |
1 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.5132 |
0 |
0.5245 |
None |
14822 |
0 |
27571 |
0 |
53.8% |
0 |
1 |
0.5 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.3263 |
0 |
0.3443 |
None |
681 |
0 |
2016 |
0 |
33.8% |
0 |
0.5 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
56 |
0 |
35.7% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
46 |
0 |
28.3% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
617 |
0 |
1761 |
0 |
35.0% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
41 |
0 |
39.0% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
89 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
681 |
0 |
2016 |
0 |
33.8% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
588 |
0 |
1551 |
0 |
37.9% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
72 |
0 |
327 |
0 |
22.0% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
21 |
0 |
138 |
0 |
15.2% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
681 |
0 |
2016 |
0 |
33.8% |
0 |
N/A |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Ventura County Medical Center |
DPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.9853 |
0 |
0.92 |
None |
1330 |
0 |
1350 |
0 |
98.5% |
0 |
1 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.5 |
0 |
0.542 |
None |
175 |
0 |
260 |
0 |
67.3% |
0 |
1 |
0 |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
1.0334 |
0 |
0 |
None |
14 |
0 |
15.113 |
0 |
0.9264 |
0 |
0 |
N/A |
Yes |
PY5 |
Ventura County Medical Center |
DPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0.7593 |
0 |
0.795 |
None |
4 |
0 |
7.012 |
0 |
0.5705 |
0 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-BH2 |
Q-DRR-E |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-BH5 |
Q-FUI |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI)* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-BH6 |
Q-POD |
Pharmacotherapy for Opioid Use Disorder* |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.7157 |
0 |
0.6679 |
None |
247 |
0 |
360 |
0 |
68.6% |
0 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.9462 |
0 |
0.9199 |
None |
157 |
0 |
176 |
0 |
89.2% |
0 |
N/A |
N/A |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.6726 |
0 |
0.6892 |
None |
228 |
0 |
320 |
0 |
71.3% |
0 |
1 |
0 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Black/African-American |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
4 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Hispanic/Latino |
Reported |
None |
2 |
0.3406 |
None |
None |
1 |
37 |
0 |
None |
1 |
1 |
N/A |
YesS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Total Population |
Reported |
0.2121 |
0 |
0.3406 |
None |
44 |
0 |
199 |
0 |
22.1% |
0 |
1 |
N/A |
YesS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9)* |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
16 |
0 |
86 |
0 |
18.6% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
13 |
0 |
60 |
0 |
21.7% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
44 |
0 |
199 |
0 |
22.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
37 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
35 |
0 |
160 |
0 |
21.9% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD1 |
Q-HBD |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
44 |
0 |
199 |
0 |
22.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD2 |
Q-EED |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.5515 |
0 |
0.5594 |
None |
95 |
0 |
199 |
0 |
47.7% |
0 |
N/A |
N/A |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAD3 |
Q-KED |
Kidney Health Evaluation for Patients with Diabetes |
Reported |
0.5604 |
0 |
0.4676 |
None |
147 |
0 |
217 |
0 |
67.7% |
0 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CC1 |
Q-TRC |
Transitions of Care (TRC) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-CC2 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
None |
2 |
0.22 |
None |
None |
1 |
43 |
0 |
None |
1 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.6636 |
0 |
0.6734 |
None |
82 |
0 |
117 |
0 |
70.1% |
0 |
1 |
0.5 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-MPH6 |
Q-PRS-E |
Prenatal Immunization Status |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.6471 |
0 |
0.6377 |
None |
144 |
0 |
207 |
0 |
69.6% |
0 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.4491 |
0 |
0.476 |
None |
1719 |
0 |
3688 |
0 |
46.6% |
0 |
N/A |
N/A |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 2 |
Reported |
0.2177 |
0 |
0.2879 |
None |
49 |
0 |
277 |
0 |
17.7% |
0 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 3 |
Reported |
0.9158 |
0 |
0.9195 |
None |
3464 |
0 |
3782 |
0 |
91.6% |
0 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
â¶ Rate 1 (informational only) |
Reported |
0.9756 |
0 |
0 |
None |
3692 |
0 |
3782 |
0 |
97.6% |
0 |
N/A |
N/A |
NoI |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Physical Activity |
Reported |
0.8055 |
0 |
0.7932 |
None |
417 |
0 |
562 |
0 |
74.2% |
0 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ Counseling for Nutrition |
Reported |
0.8123 |
0 |
0.8136 |
None |
416 |
0 |
562 |
0 |
74.0% |
0 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
â¶ BMI |
Reported |
0.8925 |
0 |
0.8718 |
None |
475 |
0 |
562 |
0 |
84.5% |
0 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
â¶ 15 Months-30 Months |
Reported |
0.6774 |
0 |
0.6925 |
None |
38 |
0 |
58 |
0 |
65.5% |
0 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC16 |
Q-W30 |
â¶ First 15 Months |
Reported |
None |
2 |
N/A |
None |
None |
1 |
None |
1 |
None |
1 |
N/A |
N/A |
NoS |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.6673 |
0 |
0.6686 |
None |
410 |
0 |
586 |
0 |
70.0% |
0 |
1 |
0.5 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.5532 |
0 |
0.5599 |
None |
461 |
0 |
1069 |
0 |
43.1% |
0 |
N/A |
N/A |
No |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
154 |
0 |
347 |
0 |
44.4% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
37 |
0 |
77 |
0 |
48.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
63 |
0 |
161 |
0 |
39.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
20 |
0 |
47 |
0 |
42.6% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
178 |
0 |
414 |
0 |
43.0% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
461 |
0 |
1069 |
0 |
43.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
129 |
0 |
289 |
0 |
44.6% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
323 |
0 |
629 |
0 |
51.4% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
151 |
0 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC3 |
Q-WCV |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
461 |
0 |
1069 |
0 |
43.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
Childhood Immunization Status (CIS 10) |
Reported |
0.3 |
0 |
0.3237 |
None |
19 |
0 |
53 |
0 |
35.9% |
0 |
1 |
0 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
53 |
0 |
35.9% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
18 |
0 |
34 |
0 |
52.9% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC4 |
Q-CIS |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
19 |
0 |
53 |
0 |
35.9% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.6515 |
0 |
0.6525 |
None |
44 |
0 |
64 |
0 |
68.8% |
0 |
1 |
1 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.2727 |
0 |
0.2821 |
None |
31 |
0 |
95 |
0 |
32.6% |
0 |
1 |
1 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.2708 |
0 |
0.309 |
None |
26 |
0 |
61 |
0 |
42.6% |
0 |
1 |
1 |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : American Indian or Alaska Native |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
0 |
0 |
0.0% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Asian |
Reported |
N/A |
3 |
N/A |
3 |
12 |
0 |
None |
4 |
None |
4 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Black or African American |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Native Hawaiian or Other Pacific Islander |
Reported |
N/A |
3 |
N/A |
3 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : White |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Two or More Races |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Other/Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Race : Total |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
61 |
0 |
42.6% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Not Hispanic or Latino |
Reported |
N/A |
3 |
N/A |
3 |
23 |
0 |
41 |
0 |
56.1% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Declined/Unknown |
Reported |
N/A |
3 |
N/A |
3 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PC9 |
Q-IMA |
â¶ Ethnicity : Total |
Reported |
N/A |
3 |
N/A |
3 |
26 |
0 |
61 |
0 |
42.6% |
0 |
N/A |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PS4 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.1572 |
0 |
0.58 |
None |
7 |
0 |
38.282 |
0 |
0.1829 |
0 |
1 |
N/A |
Yes |
PY5 |
Washington Hospital Healthcare District |
DMPH |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |